Integrating Genomics and Phenomics in Personalised Health

First published 2024

The transition from genomics to phenomics in personalised population health represents a significant shift in approach. This change involves expanding beyond genetic information to encompass a comprehensive view of an individual’s health. It includes analysing various biological levels like the genome, epigenome, proteome, and metabolome, as well as considering lifestyle factors, physiology, and data from electronic health records. This integrative approach enables a more thorough understanding of health and disease, facilitating the development of personalised health strategies. This multifaceted perspective allows for better tracking and interpretation of health metrics, leading to more effective and tailored healthcare interventions.

Profiling the many dimensions of health in the context of personalised population health involves a comprehensive assessment of various biological and environmental factors. The genome, serving as the blueprint of life, is assayed through technologies like single-nucleotide polymorphism chips, whole-exome sequencing, and whole-genome sequencing. These methods identify the genetic predispositions and susceptibilities of individuals, offering insights into their health.

Contact

The epigenome, which includes chemical modifications of the DNA, plays a crucial role in gene expression regulation. Techniques like bisulfite sequencing and chromatin immunoprecipitation followed by sequencing have enabled the study of these modifications, revealing their influence on various health conditions like aging and cancer. The epigenome’s responsiveness to external factors like diet and stress highlights its significance in personalised health.

The Role of mRNA in Personalised Medicine

Proteomics, the study of the proteome, involves the analysis of the myriad of proteins present in the body. Advances in mass spectrometry and high-throughput technologies have empowered researchers to explore the complex protein landscape, which is critical for understanding various diseases and physiological processes.

The metabolome, encompassing the complete set of metabolites, reflects the biochemical activity within the body. Metabolomics, through techniques like mass spectrometry, provides insights into the metabolic status and can be crucial in disease diagnosis and monitoring.

The microbiome, consisting of the microorganisms living in and on the human body, is another critical aspect of health profiling. The study of the microbiome, particularly through sequencing technologies, has unveiled its significant role in health and disease, influencing various bodily systems like the immune and digestive systems.

Lifestyle factors and physiology, including diet, exercise, and daily routines, are integral to health profiling. Wearable technologies and digital health tools have revolutionised the way these factors are monitored, providing real-time data on various physiological parameters like heart rate, sleep patterns, and blood glucose levels.

Lastly, electronic health records (EHRs) offer a wealth of clinical data, capturing patient interactions with healthcare systems. The integration of EHRs with other health data provides a comprehensive view of an individual’s health status, aiding in the personalised management of health.

Overall, the multidimensional approach to health profiling, encompassing genomics, epigenomics, proteomics, metabolomics, microbiomics, lifestyle factors, physiology, and EHRs, is pivotal in advancing personalised population health. This integrated perspective enables a more accurate assessment and management of health, moving towards a proactive and personalised healthcare paradigm.

Advancing Bioinformatics: Integrating Data and Dynamics

Integrating different data types to track health, understand phenomic signatures of genomic variation, and translate this knowledge into clinical utility is a complex but promising area of personalised population health. The integration of multimodal data, such as genomic and phenomic data, provides a comprehensive understanding of health and disease. This approach involves defining metrics that can accurately track health and reflect the complex interplay between various biological systems.

Precision Medicine in Idiopathic Pulmonary Fibrosis

One key aspect of this integration is understanding the phenomic signatures of genomic variation. Genomic data, such as genetic predispositions and mutations, can be linked to phenomic expressions like protein levels, metabolic profiles, and physiological responses. This connection allows for a deeper understanding of how genetic variations manifest in physical traits and health outcomes. Translating this integrated knowledge into clinical utility involves developing actionable recommendations based on a patient’s unique genomic and phenomic profile. This can lead to more personalised treatment plans, which may include lifestyle changes, diet, medication, or other interventions specifically tailored to an individual’s health profile. For example, the identification of specific biomarkers through deep phenotyping can indicate the onset of certain diseases, like cancer, before clinical symptoms appear.

The Implications of Artificial Intelligence Integration within the NHS

Another critical element is the application of advanced computational tools and artificial intelligence to analyse and interpret the vast amounts of data generated. These technologies can identify patterns and associations that might not be evident through traditional analysis methods. By effectively integrating and analysing these data, healthcare providers can gain a more detailed and accurate understanding of an individual’s health, leading to better disease prevention, diagnosis, and treatment strategies. The integration of diverse data types in personalised population health therefore represents a significant advancement in our ability to understand and manage health at an individual level.

The Use of Machine Learning Models in Healthcare

Adopting personalised approaches to population health presents several challenges and potential solutions. One of the main challenges is the complexity of integrating diverse types of health data, such as genomic, proteomic, metabolomic, and lifestyle data. This integration requires advanced computational tools and algorithms capable of handling large, heterogeneous datasets and extracting meaningful insights from them. Another significant challenge lies in translating these insights into practical, actionable strategies in clinical settings. Personalised health strategies need to be tailored to individual genetic and phenomic profiles, taking into account not only the presence of certain biomarkers or genetic predispositions but also lifestyle factors and environmental exposures.

Revolutionising Patient Data: The Role of Coding and AI in the NHS

To address these challenges, solutions include the development of more sophisticated data integration and analysis tools, which can handle the complexity and volume of multimodal health data. Additionally, fostering closer collaboration between researchers, clinicians, and data scientists is crucial to ensure that insights from data analytics are effectively translated into clinical practice. Moreover, there is a need for standardisation in data collection, processing, and analysis to ensure consistency and reliability across different studies and applications. This standardisation also extends to the ethical aspects of handling personal health data, including privacy concerns and data security.

The NHS Digital Clinical Safety Strategy: Towards Safer and Digitally Enabled Care

Implementing personalised health approaches also requires a shift in healthcare infrastructure and policies to support these advanced methods. This includes training healthcare professionals in the use of these technologies and ensuring that health systems are equipped to handle and use large amounts of data effectively. While the transition to personalised population health is challenging due to the complexity and novelty of the required approaches, these challenges can be overcome through technological advancements, collaboration across disciplines, standardisation of practices, and supportive healthcare policies.

Social Prescribing in the NHS: Challenges, Impact, and Future Directions

The main findings and perspectives presented in this essay focus on the transformative potential of integrating genomics and phenomics in personalised population health. This integration enables a more nuanced understanding of individual health profiles, considering not only genetic predispositions but also the expression of these genes in various phenotypes. The comprehensive profiling of health through diverse data types – genomics, proteomics, metabolomics, and others – provides a detailed picture of an individual’s health trajectory. The study of phenomic signatures of genomic variation has emerged as a crucial aspect in understanding how genetic variations manifest in physical and health outcomes. The ability to define metrics that accurately track health, considering both genetic and phenomic data, is seen as a significant advancement. These metrics provide new insights into disease predisposition and progression, allowing for earlier and more precise interventions. However, the translation of these insights into clinical practice poses challenges, primarily due to the complexity and volume of data involved. The need for advanced computational tools and AI to analyse and interpret these data is evident. These tools not only manage the sheer volume of data but also help in discerning patterns and associations that might not be evident through traditional analysis methods.

Despite these challenges, the integration of various health data types is recognised as a pivotal step towards a more personalised approach to healthcare. This approach promises more effective disease prevention, diagnosis, and treatment strategies tailored to individual health profiles. It represents a shift from a one-size-fits-all approach in medicine to one that is predictive, preventative, and personalised.

Links

Yurkovich, J.T., Evans, S.J., Rappaport, N. et al. The transition from genomics to phenomics in personalized population health. Nat Rev Genet (2023). https://doi.org/10.1038/s41576-023-00674-x

https://createanessay4u.wordpress.com/tag/healthcare/

https://createanessay4u.wordpress.com/tag/ai/

https://createanessay4u.wordpress.com/tag/data/

https://www.sciencedirect.com/topics/agricultural-and-biological-sciences/phenomics

https://link.springer.com/journal/43657

https://www.who.int/docs/default-source/gho-documents/global-health-estimates/ghe2019_life-table-methods.pdf

https://www.nature.com/articles/520609a

Redefining Computing with Quantum Advantage

First published 2024

This CreateAnEssay4U special edition brings together the work of previous essays and provides a comprehensive overview of an important technological area of study. For source information, see also:

https://createanessay4u.wordpress.com/tag/quantum/

https://createanessay4u.wordpress.com/tag/computing/

In the constantly changing world of computational science, principles of quantum mechanics are shaping a new frontier, set to transform the foundation of problem-solving and data processing. This emerging frontier is characterised by a search for quantum advantage – a pivotal moment in computing, where quantum computers surpass classical ones in specific tasks. Far from being just a theoretical goal, this concept is a motivating force for the work of physicists, computer scientists, and engineers, aiming to unveil capabilities previously unattainable.

Central to this paradigm shift is the quantum bit or qubit. Unlike classical bits restricted to 0 or 1, qubits operate in a realm of quantum superposition, embodying both states simultaneously. This capability drastically expands computational potential. For example, Google’s quantum computer, Sycamore, used qubits to perform calculations that would be impractical for classical computers, illustrating the profound implications of quantum superposition in computational tasks.

Contact

The power of quantum computing stems from the complex interaction of superposition, interference, and entanglement. Interference, similar to the merging of physical waves, manipulates qubits to emphasise correct solutions and suppress incorrect ones. This process is central to quantum algorithms, which, though challenging to develop, harness interference patterns to solve complex problems. An example of this is IBM’s quantum computer, which uses interference to perform complex molecular simulations, a task far beyond the reach of classical computers.

Entanglement in quantum computing creates a unique correlation between qubits, where the state of one qubit is intrinsically tied to another, irrespective of distance. This “spooky action at a distance” allows for a collective computational behavior surpassing classical computing. Quantum entanglement was notably demonstrated in the University of Maryland’s quantum computer, which used entangled qubits to execute algorithms faster than classical computers could.

The Advantages of Quantum Algorithms Over Classical Limitations of Computation

Quantum computing’s applications are vast. In cryptography, quantum computers can potentially break current encryption algorithms. For instance, quantum algorithms developed at MIT have shown the ability to crack encryption methods that would otherwise be secure against classical computational attacks. This has spurred the development of quantum-resistant algorithms in post-quantum cryptography.

Quantum Shift: Preparing for Post-Quantum Cryptography

Quantum simulation, a key application of quantum computing, was envisioned by physicist Richard Feynman and is now close to reality. Quantum computers, like those developed at Harvard University, use quantum simulation to model complex molecular structures, significantly impacting drug discovery and material science.

Quantum sensing, an application of quantum information technology, leverages quantum properties for precise measurements. A prototype quantum sensor developed by MIT researchers, capable of detecting various electromagnetic frequencies, exemplifies the advanced capabilities of quantum sensing in fields like medical imaging and environmental monitoring.

Quantum Computing: Unlocking the Complexities of Biological Sciences

The concept of a quantum internet interconnecting quantum computers through secure protocols is another promising application. The University of Chicago’s recent experiments with quantum key distribution demonstrate how quantum cryptography can secure communications against even quantum computational attacks.

Quantum Computing and the Future of Cryptography

Despite these applications, quantum computing faces challenges, particularly in hardware and software development. Quantum computers are prone to decoherence, where qubits lose their quantum properties. Addressing this, researchers at Stanford University have developed techniques to prolong qubit coherence, a crucial step towards practical quantum computing.

The quantum computing landscape is rich with participation from startups and established players like Google and IBM, and bolstered by government investments. These collaborations accelerate advancements, as seen in the development of quantum error correction techniques at the University of California, Berkeley, enhancing the stability and reliability of quantum computations.

Early demonstrations of quantum advantage have been seen in specialised applications. Google’s achievement in using quantum computers for complex tasks like random number generation is an example. However, the threat of a “quantum winter,” a period of reduced interest and investment, looms if practical applications don’t quickly materialise.

In conclusion, quantum advantage represents a turning point in computing, propelled by quantum mechanics. Its journey is complex, with immense potential for reshaping various fields. As this field evolves, it promises to tackle complex problems, from cryptography to material science, marking a transformative phase in technological advancement.

This CreateAnEssay4U special edition brings together the work of previous essays and provides a comprehensive overview of an important technological area of study. For source information, see also:

https://createanessay4u.wordpress.com/tag/quantum/

https://createanessay4u.wordpress.com/tag/computing/

Links

https://www.nature.com/articles/s41586-022-04940-6

https://www.quantumcomputinginc.com/blog/quantum-advantage/

https://www.ft.com/content/e70fa0ce-d792-4bc2-b535-e29969098dc5

https://semiengineering.com/the-race-toward-quantum-advantage/

https://www.cambridge.org/gb/universitypress/subjects/physics/quantum-physics-quantum-information-and-quantum-computation/

The Promise and Challenges of Silver Nanowire Networks

First published 2024

The fascination with artificial intelligence (AI) stems from its ability to handle massive data volumes with superhuman efficiency. Traditional AI systems depend on computers running complex algorithms through artificial neural networks, but these systems consume significant energy, particularly when processing real-time data. To address this, a novel approach to machine intelligence is being pursued, shifting from software-based artificial neural networks to more efficient physical neural networks in hardware, specifically using silver nanowires.

Silver nanowires, only a few nanometres in diameter, offer a more efficient alternative to conventional graphical processing units (GPUs) and neural chips. These nanowires form dense neuron networks, surpassing the efficiency of computer-based AI systems. Their small size allows for more densely packed networks, enhancing information processing speed and complexity. The nanowires’ flexibility and durability further add to their appeal, being adaptable to different configurations and more resistant to wear compared to traditional AI systems. Their operation at the speed of light significantly surpasses the electrical speed of GPUs and neural chips, leading to faster processing speeds. This, coupled with the high conductivity of silver, allows these nanowires to operate at lower voltages, thereby reducing power consumption. Their small size is particularly beneficial for integration into compact devices like smartphones and wearables. Moreover, their ability to multitask means they can process more information in less time, enhancing their suitability for various AI applications.

Contact

While the advancements in using silver nanowires for AI are promising, they are accompanied by several challenges. Their high cost limits accessibility, particularly for smaller firms and startups, and the nanowires’ limited availability complicates their integration into a wide range of products. Additionally, the fragility of silver nanowires may compromise their durability, requiring careful handling to prevent damage and making them potentially less robust than traditional GPUs and neural chips. Furthermore, despite their rapid data processing capabilities, silver nanowires may not yet rival the performance of GPUs in high-performance computing or be as efficient in handling large-scale data processing.

In contrast, the field of neuromorphic computing, which aims to replicate the complex neuron topology of the brain using nanomaterials, is making significant strides. Networks composed of silver nanowires and nanoparticles are particularly noteworthy for their resistive switching properties, akin to memristors, which enhance network adaptability and plasticity. A prime example of this is Atomic Switch Networks (ASNs) made of Ag2S junctions. In these networks, dendritic Ag nanowires form interconnected atomic switches, effectively emulating the dense connectivity found in biological neurons. These networks have shown potential in various natural computing paradigms, including reservoir computing, highlighting the diverse applications of these innovative neural network architectures.

Further explorations in creating neuromorphic networks have involved self-assembled networks of nanowires or nanoparticles, such as those formed from metal oxide nanoparticles like gold or tin. These networks display neuromorphic properties due to their resistive switches and show recurrent properties crucial for neuromorphic applications. Such advancements in the field of AI, particularly with the use of silver nanowires, point to a future where computing not only becomes more efficient but also more closely emulates the complex processes of the human brain. These developments indicate the potential for revolutionary changes in how data is processed and learned, paving the way for more advanced and energy-efficient AI systems.

A recent approach in neuromorphic computing demonstrates the capability of neural networks of silver nanowires to learn and recognise handwritten numbers and memorise digit strings, with findings published in Nature Communications (2023), in collaboration with researchers from the University of Sydney and the University of California, Los Angeles. The team employs nanotechnology to create networks of silver nanowires, each about one thousandth the width of a human hair. These networks form randomly, resembling the brain’s neuron network. In these networks, external electrical signals prompt changes at the intersections of nanowires, mimicking the function of biological synapses. With tens of thousands of these synapse-like junctions, these networks efficiently process and transmit information.

A significant aspect of this research is the demonstration of real-time, online machine learning capabilities of nanowire networks, in contrast to conventional batch-based learning in AI. Unlike traditional systems that process data in batches, this approach allows continuous data stream processing, enabling the system to learn and adapt instantly. This “on the fly” learning reduces the need for repetitive data processing and extensive memory requirements, resulting in substantial energy savings and increased efficiency.

The team tested the nanowire network’s learning and memory capabilities using the Modified National Institute of Standards and Technology (MNIST) database of handwritten digits. The network successfully learned and improved its pattern recognition with each new digit, showcasing real-time learning. Additionally, the network was tested on memory tasks involving digit patterns, demonstrating an aptitude for remembering sequences, akin to recalling a phone number.

These experiments highlight the potential of neuromorphic nanowire networks in emulating brain-like learning and memory processes. This research represents just the beginning of unlocking the full capabilities of such networks, indicating a promising future for AI development. The implications of these findings are far-reaching. Nanowire Network (NWN) devices could be used in areas such as natural language processing and image analysis, making the most of their ability to learn and remember dynamic sequences. The study points to the possibility of NWNs contributing to new types of computational applications, moving beyond the traditional limits of the Turing Machine concept and based on real-world physical systems.

In conclusion, the exploration of silver nanowires in artificial intelligence marks a significant shift towards more efficient, brain-like computing. These nanowires, mere nanometres in diameter, present a highly efficient alternative to traditional GPUs and neural chips, forming densely packed neuron networks that excel in processing speed and complexity. Their adaptability, durability, and ability to operate at lower voltages highlight the potential for integration into various compact devices and AI applications.

However, challenges such as high cost, limited availability, and fragility temper the widespread adoption of silver nanowires, along with their current limitations in matching the performance of GPUs in certain high-demand computing tasks. Despite these hurdles, the advancements in neuromorphic computing using silver nanowires and other nanomaterials are promising. Networks like Atomic Switch Networks (ASNs) demonstrate the potential of these materials in replicating the complex connectivity and functionality of biological neurons, paving the way for breakthroughs in natural computing paradigms.

The 2023 study showcasing the online learning and memory capabilities of silver nanowire networks, especially in tasks like recognising handwritten numbers and memorising digit sequences, represents a leap forward in AI research. These networks, capable of processing data streams in real time, offer a more energy-efficient and dynamic approach to machine learning, differing fundamentally from traditional batch-based methods. This approach not only saves energy but also mimics the human brain’s ability to learn and recall quickly and efficiently.

As the field of AI continues to evolve, silver nanowires and neuromorphic networks stand at the forefront of research, potentially revolutionising how data is processed and learned. Their application in areas such as natural language processing and image analysis could harness their unique learning and memory abilities. This research, still in its early stages, opens the door to new computational applications that go beyond conventional paradigms, drawing inspiration from the physical world and the human brain. The future of AI development, influenced by these innovations, holds immense promise for more advanced, efficient, and brain-like artificial intelligence systems.

Links

https://nanografi.com/blog/silver-nanowires-applications-nanografi-blog/

https://www.techtarget.com/searchenterpriseai/definition/neuromorphic-computing

https://www.nature.com/articles/s41467-023-42470-5

https://www.nature.com/articles/s41598-019-51330-6

https://paperswithcode.com/dataset/mnist

The Evolutionary Journey of Artificial Intelligence

First published 2024

The goal to replicate human cognition through machines, known as artificial intelligence (AI), is a discipline that spans a mere six decades. Its roots can be traced back to a period post the Second World War, where AI emerged as a confluence of various scientific fields including mathematical logic, statistics, computational neurobiology, and computer science. Its aim? To mimic human cognitive abilities.

The inception of AI was profoundly influenced by the technological strides during the 1940-1960 period, a phase known as the birth of AI in the annals of cybernetics. This era was characterised by the fusion of technological advancements, catalysed further by the Second World War, and the aspiration to amalgamate the functions of machines and organic beings. Figures like Norbert Wiener envisaged a synthesis of mathematical theory, electronics, and automation to facilitate communication and control in both animals and machines. Furthermore, Warren McCulloch and Walter Pitts developed a pioneering mathematical and computer model of the biological neuron as early as 1943.

Contact

By the 1950s, notable contributors like John Von Neumann and Alan Turing were laying the technical groundwork for AI. They transitioned computing from the realm of decimal logic to binary logic, thus setting the stage for modern computing. Turing, in his seminal 1950 article, posited the famous “imitation game” or the Turing Test, an experiment designed to question the intelligence of a machine. Meanwhile, the term “AI” itself was coined by John McCarthy from MIT, further defined by Marvin Minsky as the creation of computer programs that replicate tasks typically accomplished more effectively by humans.

Although the late 1950s were marked by lofty prophecies, such as Herbert Simon’s prediction that AI would soon outperform humans in chess, the subsequent decades were not as generous to AI. Technology, despite its allure, faced a downturn in the early 1960s, primarily due to the limited memory of machines. Notwithstanding these limitations, some foundational elements persisted, like solution trees to solve problems.

Fast-forward to the 1980s and 1990s, AI experienced a resurgence with the emergence of expert systems. This resurgence was ignited by the advent of the first microprocessors in the late 1970s. Systems such as DENDRAL and MYCIN exemplified the potential of AI, offering highly specialised expertise. Despite this boom, by the late 1980s and early 1990s, the fervour surrounding AI diminished once more. Challenges in programming and system maintenance, combined with more straightforward and cost-effective alternatives, rendered AI less appealing.

However, post-2010 marked a transformative era for AI, fuelled predominantly by two factors: unprecedented access to vast data and substantial enhancement in computing power. For instance, prior to this decade, algorithms for tasks such as image classification required intensive manual data sampling. Now, with tools like Google, millions of samples could be accessed with ease. Furthermore, the discovery of the efficiency of graphic card processors in expediting the calculations of learning algorithms presented a game-changer.

These technological advancements spurred notable achievements in AI. For example, Watson, IBM’s AI system, triumphed over human contestants in the game Jeopardy in 2011. Google X’s AI managed to recognise cats in videos, a seemingly trivial task but one that heralded the machine’s learning capacity. These accomplishments symbolise a paradigm shift from the traditional expert systems to an inductive approach. Rather than manual rule coding, machines were now trained to autonomously discover patterns and correlations using vast datasets.

Deep learning, a subset of machine learning, has exhibited significant promise, particularly in tasks like voice and image recognition. Spearheaded by researchers like Geoffrey Hinton, Yoshua Bengio, and Yann LeCun, deep learning has revolutionised fields such as speech recognition. Despite these breakthroughs, challenges persist. While devices can transcribe human speech, the nuanced understanding of human text and intention still eludes AI.

The rise of artificial intelligence in the modern era has led to the emergence of sophisticated systems, one of the most noteworthy being generative AI. Generative AI refers to the subset of artificial intelligence algorithms and models that use techniques from unsupervised machine learning to produce content. It seeks to create new content that resembles the data it has been trained on, for example, images, music, text, or even more complex data structures. It’s a profound leap from the traditional, deterministic AI systems to models that can generate and innovate, mirroring the creative processes that were once thought exclusive to human cognition.

A groundbreaking example of generative AI is the Generative Adversarial Network (GAN). Proposed by Ian Goodfellow and his colleagues in 2014, GANs consist of two neural networks – a generator and a discriminator – that are trained concurrently. The generator produces synthetic data, while the discriminator tries to distinguish between real data and the fake data produced by the generator. Over time, the generator becomes increasingly adept at creating data that the discriminator can’t distinguish from real data. This iterative process has allowed for the creation of incredibly realistic images, artworks, and other types of content. It is analogous to a forger trying to create a painting, while an art detective determines its authenticity. The constant duel between the two refines the forger’s skill, allowing for more realistic and convincing creations.

Another influential instance of generative AI is in the realm of natural language processing. Models like OpenAI’s GPT series have redefined what machines can generate in terms of human-like text. These models use vast amounts of text data to train, allowing them to produce coherent and contextually relevant sentences and paragraphs that can be almost indistinguishable from human-written content. Such advancements are indicative of the vast potential of generative models in various domains, from content creation to human-computer interaction.

However, the capabilities of generative AI have raised pertinent ethical concerns. The ability to generate realistic content, whether as deepfakes in videos or fabricated news articles, poses significant challenges in discerning authenticity in the digital age. Misuse of these technologies can lead to misinformation, identity theft, and other forms of cyber deception. Consequently, as researchers and practitioners continue to refine and push the boundaries of generative AI, there’s an imperative need to consider the broader societal implications and integrate safeguards against potential misuse.

Despite these concerns, the potential benefits of generative AI are undeniable. From personalised content generation in media and entertainment to rapid prototyping in design and manufacturing, the applications are vast. Moreover, generative models hold promise in scientific domains as well, aiding in drug discovery or simulating complex environmental models, thus facilitating our understanding and addressing some of the most pressing challenges of our times. As the landscape of AI continues to evolve, generative models undoubtedly stand as a testament to both the creative potential of machines and the ingenuity of human researchers who develop them.

In summary, the journey of AI has been one characterised by remarkable inventions, paradigm shifts, and periods of scepticism and renaissance. While AI has demonstrated capabilities previously thought to be the exclusive domain of humans, it is essential to note that current achievements are still categorised as “weak” or “moderate” AIs. The dream of a “strong” AI, which can autonomously contextualise and solve a diverse array of specialised problems, remains confined to the pages of science fiction. Nevertheless, as history has shown, the relentless human pursuit of knowledge, coupled with technological advancements, continues to push the boundaries of what is conceivable.

Links

https://ourworldindata.org/brief-history-of-ai

https://www.ibm.com/topics/artificial-intelligence

https://courses.cs.washington.edu/courses/csep590/06au/projects/history-ai.pdf

https://journals.sagepub.com/doi/abs/10.1177/0008125619864925

A Critical Analysis of the NHS Pharmacy First Initiative

First published 2024

The NHS Pharmacy First Initiative, a transformative approach within the UK healthcare system, seeks to alleviate the growing pressures on general practitioners (GPs) by empowering pharmacists with greater responsibilities in patient care. Launched with the objective of facilitating easier and faster access to treatment for minor conditions, this initiative stands as a pivotal shift towards optimising healthcare delivery. This essay aims to critically examine the implications, effectiveness, and challenges of the initiative, providing a comprehensive analysis of its potential to reshape primary healthcare services.

The NHS Pharmacy First Initiative was introduced to enhance healthcare accessibility and efficiency by enabling pharmacies to handle minor health conditions. This shift aimed to reduce the workload on GPs and emergency departments, thereby streamlining patient care for quicker, localised treatment. It reflects a broader strategy to use pharmacists’ expertise more effectively, ensuring patients receive timely advice and treatment without the need for a GP appointment for common or minor ailments.

MedSchool4U

The NHS Pharmacy First Initiative covers a range of services and conditions designed to offer patients direct access to treatments for minor illnesses and advice. These services include consultations and treatments for common conditions such as colds, flu, minor infections, and skin conditions. Pharmacists provide assessments, advice, and can supply medicines without the need for a GP prescription. This approach aims to make healthcare more accessible and efficient for patients while reducing the strain on general practices and emergency departments.

The expansion of pharmacists’ roles under the NHS Pharmacy First Initiative includes offering consultations, diagnosing conditions, and prescribing treatments directly. This change aims to enhance healthcare accessibility, allowing patients quicker access to medical advice and treatments for minor ailments. It is anticipated to reduce the burden on GPs and emergency services, leading to more efficient use of healthcare resources and potentially decreasing waiting times for patients needing primary care services. This approach allows patients to receive immediate care for common ailments without the need for a GP appointment, aiming to streamline the healthcare process and ensure GPs can focus on more complex cases.

By facilitating quicker access to healthcare for minor conditions directly through pharmacies, the NHS Pharmacy First Initiative aims to improve patient access to care. This accessibility can lead to early intervention and management of conditions, potentially reducing the progression of diseases and the need for more extensive medical treatment. Early intervention can improve health outcomes and contribute to the overall efficiency of the healthcare system.

Contact

The NHS Pharmacy First Initiative significantly elevates the role of pharmacists, positioning them as key healthcare providers within the NHS. This shift acknowledges their expertise and capability to deliver primary care services, including diagnosis and treatment for minor ailments, thereby enhancing the overall healthcare delivery model. However, expanding pharmacists’ scope of practice raises concerns about ensuring they have the necessary training and resources. There is a need for comprehensive education and continuous professional development to equip pharmacists with skills for diagnosing and treating a broader range of conditions. Additionally, ensuring access to adequate resources and support systems is crucial for maintaining high-quality care and patient safety.

The consistency and quality of care across different pharmacies is a further critical aspect to consider under the NHS Pharmacy First Initiative. Variability in pharmacist training, experience, and resources can lead to inconsistencies in the level of care provided to patients. Ensuring uniform standards and continuous professional development is essential to maintain high-quality care across all participating pharmacies.

The initiative’s success also hinges on ensuring patient safety, particularly in diagnosing and treating conditions without a GP’s direct involvement. This involves accurate assessment capabilities and clear guidelines for when to refer patients back to GPs or specialists, ensuring no compromise in care quality and safety.

Similar initiatives to the NHS Pharmacy First Initiative can be found in various countries, aiming to enhance healthcare accessibility and efficiency. For example, in the United States, certain states have implemented expanded pharmacy practice models, allowing pharmacists to prescribe medications for specific conditions. Similarly, in Canada, pharmacists have been granted increased authority to manage chronic conditions, adjust prescriptions, and administer vaccines. These international examples highlight a global trend towards leveraging pharmacists’ expertise to improve healthcare delivery, each with its unique set of challenges and successes in implementing such programs.

The future developments of the NHS Pharmacy First Initiative may include further expansions of services and conditions covered, as well as revisions to enhance its effectiveness based on feedback and outcomes. Potential areas for expansion could involve increasing the range of minor ailments treated by pharmacists, enhancing pharmacist training, and integrating digital health technologies to improve service delivery and patient care.

Improving the NHS Pharmacy First Initiative could involve several strategies: enhancing pharmacist training to ensure consistent, high-quality care; increasing public awareness about the services offered through targeted campaigns; and strengthening the integration with other parts of the healthcare system for seamless patient referrals and care coordination. These measures could address current limitations and maximise the initiative’s impact on public health and healthcare efficiency.

In conclusion, the NHS Pharmacy First Initiative aims to enhance primary care by enabling pharmacists to manage minor health conditions, aiming to reduce GP workload and improve patient access to healthcare. The initiative presents both opportunities for early intervention in healthcare and challenges, such as ensuring consistent quality of care and addressing scope of practice for pharmacists. Its success depends on addressing these challenges through enhanced training, public awareness, and integration with the broader healthcare system. Reflecting on its potential, the initiative could significantly transform primary care within the NHS by leveraging pharmacists’ expertise more effectively.

Links

https://www.nhsbsa.nhs.uk/pharmacies-gp-practices-and-appliance-contractors/dispensing-contractors-information/nhs-pharmacy-first-service-pfs

https://www.england.nhs.uk/publication/community-pharmacy-advanced-service-specification-nhs-pharmacy-first-service

https://healthmedia.blog.gov.uk/2024/02/01/pharmacy-first-what-you-need-to-know

Pharmacy First service

Neuromorphic Computing: Bridging Brains and Machines

First published 2024

Neuromorphic Computing represents a significant leap in the field of artificial intelligence, marking a shift towards systems that are inspired by the human brain’s structure and functionality. This innovative approach aims to replicate the complex processes of neural networks within the brain, thereby offering a new perspective on how artificial intelligence can be developed and applied. The potential of Neuromorphic Computing is vast, encompassing enhancements in efficiency, adaptability, and learning capabilities. However, this field is not without its challenges and ethical considerations. These complexities necessitate a thorough and critical analysis to understand Neuromorphic Computing’s potential impact on the future of computing and AI technologies. This essay examines these aspects, exploring the transformative nature of Neuromorphic Computing and its implications for the broader landscape of technology and artificial intelligence.

Contact

The emergence of Neuromorphic Computing signifies a pivotal development in artificial intelligence, with its foundations deeply rooted in the emulation of the human brain’s processing capabilities. This novel field of technology harnesses the principles of neural networks and brain-inspired algorithms, evolving over time to create computing systems that not only replicate brain functions but also introduce a new paradigm in computational efficiency and problem-solving. Neuromorphic Computing operates by imitating the complex network of neurons in the human brain, requiring the analysis of unstructured data in a manner that rivals the energy-efficient biological brain. Human brains, consuming less than 20 watts of power, outperform supercomputers in terms of energy efficiency. In Neuromorphic Computing, this is emulated through spiking neural networks (SNNs), where artificial neurons are layered and can independently fire, communicating with each other to initiate changes in response to stimuli.

The Intersection of Artificial Intelligence and Neurobiology

A significant advancement in this field was IBM’s demonstration of in-memory computing in 2017, using one million phase change memory devices for storing and processing information. This development, an extension of IBM’s earlier neuromorphic chip TrueNorth, marked a major reduction in power consumption for neuromorphic computers. The SNN chip used in this instance featured one million programmable neurons and 256 million programmable synapses, offering a massively parallel architecture that is both energy-efficient and powerful.

The evolution of neuromorphic hardware has been further propelled by the creation of nanoscale memristive devices, also known as memristors. These devices, functioning similarly to human synapses, store information in their resistance/conductance states and modulate conductivity based on their programming history. Memristors demonstrate synaptic efficacy and plasticity, mirroring the brain’s ability to form new pathways based on new information. This technology contributes to what is known as a massively parallel, manycore supercomputer architecture, exemplified by projects like SpiNNaker, which aims to model up to a billion biological neurons in real time.

Neuromorphic devices are increasingly used to complement and enhance traditional computing technologies such as CPUs, GPUs, and FPGA. They are capable of performing complex and high-performance tasks, such as learning, searching, and sensing, with remarkably low power consumption. An example of their real-world application includes instant voice recognition in mobile phones, which operates without the need for cloud-based processing. This integration of neuromorphic systems with conventional computing technologies marks a significant step in the evolution of AI, redefining how machines learn, process information, and interact with their environment.

Intel’s development of the Loihi chip marks a significant advancement in Neuromorphic Computing. The transition from Loihi 1 to Loihi 2 signifies more than just an upgrade in technology; it represents a convergence of neuromorphic and traditional AI accelerator architectures. This evolution blurs the previously distinct lines between the two, creating a new landscape for AI and computing. Loihi 2 introduces an innovative approach to neural processing, incorporating spikes of varying magnitudes rather than adhering to the binary values typical of traditional computing models. This advancement not only mirrors the complex functionalities of the human brain more closely but also challenges the conventional norms of computing architecture. Furthermore, the enhanced programmability of Loihi 2, capable of supporting a diverse range of neuron models, further distinguishes it from traditional computing. This flexibility allows for more intricate and varied neural network designs, pushing the boundaries of what is possible in artificial intelligence and computing.

Neuromorphic Computing, particularly through the use of Intel’s Loihi 2 chip, is finding practical applications in various complex neuron models such as resonate-and-fire models and Hopf resonators. These models are particularly useful in addressing challenging real-world optimisation problems. By harnessing the capabilities of Loihi 2, these neuron models can effectively process and solve intricate tasks that conventional computing systems struggle with. Additionally, the application of spiking neural networks, as seen in the use of Loihi 2, offers a new perspective when compared to deep learning-based networks. These networks are being increasingly applied in areas like recurrent neural networks, showcasing their potential in handling tasks that require complex, iterative processing. This shift is not just a theoretical advancement but is gradually being validated in practical scenarios, where their application in optimisation problems is demonstrating the real-world efficacy of Neuromorphic Computing.

Neuromorphic Computing, exemplified by developments like Intel’s Loihi chip, boasts significant advantages such as enhanced energy efficiency, adaptability, and advanced learning capabilities. These features mark a substantial improvement over traditional computing paradigms, especially in tasks requiring complex, iterative processing. However, the field faces several challenges. Training regimes for neuromorphic systems, software maturity, and issues related to compatibility with backpropagation algorithms present hurdles. Additionally, the reliance on dedicated hardware accelerators highlights infrastructural and investment needs. Looking ahead, the potential for commercialisation, especially in energy-sensitive sectors like space and aerospace, paints a promising future for Neuromorphic Computing. This potential is anchored in the technology’s ability to provide efficient and adaptable solutions to complex computational problems, a critical requirement in these industries.

When comparing Neuromorphic Computing with other AI paradigms, distinct technical challenges and advantages come to the forefront. Neuromorphic systems, such as those leveraging Intel’s Loihi chip, distinguish themselves through the integration of stateful neurons and the implementation of sparse network designs. These features enable a more efficient and biologically realistic simulation of neural processes, a stark contrast to the dense, often power-intensive architectures of traditional AI models. However, these advantages are not without their challenges. The unique nature of neuromorphic architectures means that standard AI training methods and algorithms, such as backpropagation, are not directly applicable, necessitating the development of new approaches and methodologies. This dichotomy highlights the innovative potential of neuromorphic computing while underscoring the need for continued research and development in this evolving field.

This essay has thoroughly explored Neuromorphic Computing within artificial intelligence, a field profoundly shaped by the complex workings of the human brain. It critically examined its development, key technical features, real-world applications, and notable challenges, particularly in training and software development. This analysis highlighted the significant advantages of Neuromorphic Computing, such as energy efficiency and adaptability, while also acknowledging its current limitations. Looking forward, the future of Neuromorphic Computing seems bright, especially in specialised areas like aerospace, where its unique features could lead to significant breakthroughs. As this technology evolves, its potential to transform the computing and AI landscape becomes increasingly apparent.

Links

https://techxplore.com/news/2023-11-neuromorphic-team-hardware-mimics-human.html

https://www.nature.com/articles/s43588-021-00184-y

https://www.intel.com/content/www/us/en/research/neuromorphic-computing.html

https://www.silicon.co.uk/expert-advice/the-high-performance-low-power-promise-of-neuromorphic-computing

Artificial Intelligence for Diabetic Eye Disease

First published 2023

Diabetes is a widespread chronic condition, with an estimated 463 million adults affected globally in 2019, a number projected to rise to 600 million by 2040. The rate of diabetes among Chinese adults has escalated from 9.7% in 2010 to 12.8% in 2018. This condition can cause serious damage to various body systems, notably leading to diabetic retinopathy (DR), a major complication that affects approximately 34.6% of diabetic patients worldwide and is a leading cause of blindness in the working-age population. The prevalence of DR is significant in various regions, including China (18.45%), India (17.6%), and the United States (33.2%).

DR often goes unnoticed in its initial stages as it does not affect vision immediately, resulting in many patients missing early diagnosis and treatment, which are crucial for preventing vision impairment. The disease is characterised by distinct retinal vascular abnormalities and can be categorised based on severity into stages ranging from no apparent retinopathy to proliferative DR, the most advanced form. Diabetic macular edema (DME), another condition that can occur at any DR stage, involves fluid accumulation in the retina and is independently assessed due to its potential to impair vision severely.

Contact

Diagnosis of DR and DME is typically made through various methods such as ophthalmoscopy, biomicroscopy, fundus photography, optical coherence tomography (OCT), and other imaging techniques. While ophthalmoscopes and slit lamps are common due to their affordability, fundus photography is the international standard for DR screening. OCT, despite its higher cost, is increasingly recognised for its diagnostic value but is not universally accessible for screening purposes.

The current status of diabetic retinopathy (DR) screening emphasises early detection to improve outcomes for diabetic patients. In the United States, the American Academy of Ophthalmology recommends annual eye exams for individuals with type 1 diabetes beginning five years after diagnosis, and immediate annual exams for those with type 2 diabetes upon diagnosis. Despite these guidelines, compliance with screening is low; a significant proportion of diabetic patients do not receive regular eye exams, with only a small percentage adhering to the recommended screening intervals.

In the United Kingdom, a national diabetic eye screening program initiated in 2003 has been credited with reducing DR as the leading cause of blindness among the working-age population. The program’s success is attributed to the high screening coverage of diabetic individuals nationwide.

Non-compliance with screening recommendations is attributed to factors such as a lack of disease awareness, limited access to medical resources, and insufficient medical insurance. Patients with more severe DR or those who already have vision impairment tend to comply more with screening, suggesting that the lack of symptoms in early DR leads to underestimation of the need for regular check-ups.

The use of telemedicine has been proposed to increase accessibility to screening, exemplified by the Singapore Integrated Diabetic Retinopathy Program, which remotely obtains fundus images for evaluation, reducing medical costs. Telemedicine has been found cost-effective, especially in large populations. Recently, the development of artificial intelligence (AI) has presented an alternative to enhance patient compliance and the efficiency of telemedicine in DR screening. AI can potentially streamline the grading of fundus images, reducing reliance on human resources and improving the screening process.

AI’s origins trace back to 1956 when McCarthy first introduced the concept. Shortly after, in 1959, Arthur Samuel coined the term “machine learning” (ML), emphasising the ability of machines to learn from data without being explicitly programmed. Deep learning (DL), a subset of ML, uses multi-layer neural networks for learning; within this, convolutional neural networks (CNNs) are specialised for image processing, featuring layers designed for pattern recognition.

CNN architectures like AlexNet, VGGNet, and ResNet have been pivotal in advancing AI, achieving high accuracy through end-to-end training on labelled image datasets and optimising parameters via backpropagation algorithms. Transfer learning, another ML technique, leverages pre-trained models on new domains, allowing for effective learning from smaller datasets.

In the medical field, AI’s image processing capabilities have significantly impacted radiology, dermatology, pathology, and ophthalmology. Specifically in ophthalmology, AI assists in diagnosing conditions like DR, glaucoma, and macular degeneration. The FDA’s 2018 approval of the first AI software for DR, IDx-DR, marked a milestone, using Topcon NW400 for capturing fundus images and analysing them via a cloud server to provide diagnostic guidance.

Further developments in AI for ophthalmology include EyeArt and Retmarker DR, both recognised for their high sensitivity and specificity in DR detection. These AI systems have demonstrated advantages in efficiency, accuracy, and reduced demand for human resources. They’ve shown to not only expedite the screening process, as evidenced by an Australian study where AI-based screening took about 7 minutes per patient, but also to outperform manual screenings in both accuracy and patient preference.

AI’s ability to analyse fundus photographs or OCT images at primary care facilities simplifies the screening process, potentially improving patient compliance and significantly reducing ophthalmologists’ workloads. With AI providing immediate grading and recommendations for follow-up or referral, diabetic patients can more easily access and undergo screening, therefore enhancing the management of DR.

To ensure the efficacy and accuracy of AI-based diagnostic systems for diabetic retinopathy (DR), it is crucial to have a well-structured dataset that is divided into separate non-overlapping sets for training, validation, and testing. In the development of AI-based diagnostic systems for diseases such as diabetic retinopathy, the dataset is meticulously organised into three distinct categories—each with a specific function in the training and validation of the algorithm. The training set forms the foundation, where the AI algorithm learns to identify and interpret fundus photographs; this set must be extensive and comprise high-quality images that have been carefully evaluated and labelled by expert ophthalmologists. As per the guidelines provided by Chinese authorities, if the system uses fundus photographs, these images should be collected from a minimum of two different medical institutions to ensure a varied and comprehensive learning experience. Concurrently, the validation set plays a pivotal role in refining the AI parameters, acting as a tool for algorithm optimisation during the development process. Lastly, the testing set is paramount for the real-world evaluation of the AI system’s clinical performance. To preserve the integrity of the results, this set is kept separate from the training and validation sets, preventing any potential biases that could skew the system’s accuracy in practical applications.

The training set should have a diverse range of images, including at least 1,000 single-field FPs or 1,000 pairs of two-field FPs, 500 non-readable FP images or pairs, and 500 images or pairs showing other fundus diseases besides DR. The images should be graded by at least three qualified ophthalmologists, with the majority opinion determining the final grade. For standard testing, a set should include 5,000 FPs or pairs, with no fewer than 2,500 images or pairs for DR stage I and above, and 500 images or pairs for other fundus diseases. A random selection of 2,000 images or pairs should be used to evaluate the AI system’s performance on the DR stages.

Current research has indicated some issues with the training sets used in existing AI systems. These include the use of FPs from a single source and including fewer than the recommended 500 non-readable images or pairs. Furthermore, some training sets sourced from online datasets do not provide access to important patient demographics like gender and age, which can be crucial for comprehensive training and accurate diagnostics.

The Iowa Detection Program (IDP) is an early example of an AI system for diabetic retinopathy (DR) screening that showed promise in Caucasian and African populations by grading fundus photographs (FP) and identifying characteristic lesions, albeit without employing deep learning (DL) techniques. Its sensitivity was commendable, but it suffered from low specificity. In contrast, IDx-DR incorporated a convolutional neural network (CNN) into the IDP framework, enhancing the specificity of DR detection. Clinical studies highlighted that while IDx-DR’s sensitivity in real-world settings didn’t quite match its testing set performance, it nonetheless demonstrated a satisfactory balance of sensitivity and specificity.

EyeArt expanded AI’s reach into mobile technology, becoming the first system to detect DR using smartphones. A study in India involving 296 type 2 diabetes patients revealed a very high sensitivity and reasonable specificity, proving its potential for remote DR screening. Moreover, systems like Google’s AI for DR screening can adjust sensitivity and specificity thresholds to meet clinical needs, suggesting that a hybrid approach of AI and manual screening could maximise efficiency and minimize missed referable DR cases.

However, most AI systems for DR rely on FPs, which are limited to two dimensions and can only detect diabetic macular edema (DME) through the presence of hard exudates in the posterior pole, potentially missing some cases. Optical coherence tomography (OCT), with its higher detection rate for DME, offers a more advanced diagnostic tool. Combining OCT with AI has led to the development of systems with impressive sensitivity, specificity, and area under the curve (AUC) metrics, as reflected in various studies. Despite these advancements, challenges such as accessibility remain, especially in resource-limited areas, as demonstrated by Hwang et al’s AI system for OCT, which still necessitates OCT equipment and the transfer of images to a smartphone, indicating that issues of accessibility for patients in underserved regions persist.

The landscape of AI-based diagnostic systems for diabetic retinopathy (DR) is expansive, yet it confronts numerous challenges. Many systems are trained on online datasets such as Messidor and EyePACS, which are limited by homogeneity in image sources and quality, as well as disease scope. These datasets often fail to encapsulate the diversity of real-world clinical environments, leading to potential misdiagnoses. A lack of standardised protocols for algorithm training exacerbates this, with the variability in sample sizes, image quality, and study designs from different sources undermining the generalisability of these AI systems.

Furthermore, while most research adheres to the International Clinical Diabetic Retinopathy Severity Scale for classifying DR severity, debates continue about its suitability. Some argue that classifications like the Early Treatment Diabetic Retinopathy Study may be more appropriate, as they could reduce unnecessary referrals by better reflecting the slower progression of milder DR forms. Inconsistencies in classification standards among studies affect both algorithm validity and cross-study comparisons.

Compounding these issues is the absence of a unified criterion for evaluating AI algorithms, with significant discrepancies in testing sets and performance metrics such as sensitivity, specificity, and area under the curve (AUC) across studies. Without universal benchmarks, comparing and validating these tools remains challenging. Moreover, AI diagnostics suffer from the “black box” phenomenon—the opaque nature of the decision-making process within AI systems. This obscurity impedes understanding and trust in the algorithms, as users cannot ascertain the rationale behind the AI’s assessments or intervene if necessary.

Legal and ethical concerns also arise, particularly regarding liability for misdiagnoses. The responsibility cannot squarely fall on either the developers or the medical practitioners using AI systems. Presently, this has restricted AI’s application primarily to DR screening. When compounded with obstacles such as cataracts, unclear media, or poor patient cooperation, the reliance on AI is reduced, necessitating ophthalmologist involvement.

Patient data security represents another critical issue. As AI systems for diabetes screening could process vast amounts of personal information, ensuring this data’s use solely for medical purposes and preventing breaches is paramount.

Finally, there’s the limitation of disease specificity in AI systems, where most are trained to detect only DR during fundus examinations. However, some studies have reported AI systems capable of identifying multiple conditions simultaneously, like age-related macular degeneration alongside DR, which could streamline diagnostic processes if widely adopted. Addressing these multifaceted challenges is crucial for the advancement and reliable integration of AI into ophthalmic diagnostics.

Artificial intelligence (AI) holds considerable promise in the field of diabetic retinopathy (DR) screening and diagnosis, with the potential to reshape current approaches significantly. The future could see the proliferation of AI systems designed for portable devices, such as smartphones, enabling patients to conduct DR screenings at home, which may drastically reduce the dependency on professional medical staff and advanced medical equipment. This shift could make DR screening much more accessible, particularly under the constraints imposed by events like the COVID-19 pandemic, where telemedicine’s importance has surged, providing vast benefits and convenience to both patients and healthcare providers.

Most AI-assisted DR screening systems currently rely on traditional fundus imaging. However, as newer examination techniques evolve, AI is expected to integrate with diverse types of ocular assessments, such as multispectral fundus imaging and optical coherence tomography (OCT), which could further enhance diagnostic accuracy. Beyond screening, AI is poised to play a crucial role in DR diagnosis. Some studies have already shown that AI can match or even surpass the sensitivity of human ophthalmologists, supporting the potential of AI-assisted systems to augment the diagnostic process with higher precision and efficiency.

Overall, in countries where DR screening programs are established, integrating AI-based diagnostic systems could significantly alleviate human resource burdens and boost operational efficiency. Despite the optimism, the datasets currently used to train AI algorithms are somewhat restricted in scope. For AI to be more broadly applicable in clinical settings, it’s essential to leverage diverse clinical resources to create more varied datasets and to refine standards for image quality and labeling, ensuring AI systems are both standardised and effective. At this juncture, the technology is not yet at a point where it can replace ophthalmologists entirely. Therefore, in the interim, a combined approach where AI complements the work of medical professionals may offer the most realistic and advantageous path forward for the clinical adoption of AI in DR management.

Links

https://www.gov.uk/guidance/diabetic-eye-screening-programme-overview

https://drc.bmj.com/content/5/1/e000333

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9559815/

https://www.mdpi.com/2504-2289/6/4/152

https://www.thelancet.com/journals/landig/article/PIIS2589-7500(20)30250-8/fulltext

https://diabetesatlas.org/

https://pubmed.ncbi.nlm.nih.gov/20580421/

https://www.aao.org/education/preferred-practice-pattern/diabetic-retinopathy-ppp

https://pubmed.ncbi.nlm.nih.gov/27726962/

https://onlinelibrary.wiley.com/doi/10.1046/j.1464-5491.2000.00338.x

https://iovs.arvojournals.org/article.aspx?articleid=2565719

The Detrimental Effects of Social Networks on Relationships

First published 2023

The evolution of technology and the digital realm has fundamentally transformed various facets of human existence, among which the domain of romantic relationships stands out prominently. With the advent of the internet, there was a paradigm shift in how individuals socialise, communicate, and connect, giving birth to a new age of virtual relationships. Over the past decade, especially, the reliance on technology has surged exponentially, with traditional methods of forming connections being replaced by their digital counterparts. Social networks, dating apps, and messengers have burgeoned into the primary mediums through which romantic entanglements are pursued, forging a new path for modern love stories. Burch (2020) underscores this transformation, noting that for the past 5-10 years, relationships across the globe have increasingly migrated to these digital platforms. As these platforms become integral to the daily lives of nearly 67.8% of the global population, as of 2021, there’s an imperative need to evaluate the implications of this shift. Do these platforms, with their sophisticated algorithms and vast user bases, enhance the quality of romantic relationships, or do they inadvertently introduce complexities that challenge the very essence of human connection?

Contact

In recent years, the landscape of romantic relationships has experienced a significant shift due to the rise of social networks, dating apps, and messengers. According to Burch (2020), over the past 5-10 years, the majority of global relationships are no longer constructed in the traditional face-to-face realm. Instead, they’ve largely migrated to the digital domain, with about 67.8% of the global population actively engaging on social platforms in 2021. These platforms, equipped with matching tools, recommendation systems, and advanced algorithms, have become integral to our daily online activities, such as exchanging comments, posting notes, and socialising.

However, these advanced systems present a narrowed and highly rationalised scope for acquaintanceship. The algorithms make it straightforward for users to filter their preferences, ranging from the external traits to more formal criteria such as education, career trajectories, or place of residence. As these algorithms continue to evolve, there’s a looming possibility that the criteria for selecting a potential partner could be entirely handed over to the machines. For many, the convenience and safety offered by platforms like Pure or Tinder are undeniable. Users feel secure knowing that they won’t be contacted unless there’s mutual interest, as determined by the infamous “swipe right” mechanism. Yet, despite these advantages, multiple downsides emerge from relying on such platforms for romantic pursuits.

Firstly, the sheer volume of choices these platforms provide can paradoxically hinder rather than facilitate meaningful connection. A study by the University of Edinburgh suggested that an abundance of options leads to decreased satisfaction. Participants who had to choose from a larger pool of 24 candidates were not only less satisfied but were also more likely to change their selection the subsequent week, compared to those who chose from a pool of just six (Riley, 2019). The human mind, when overwhelmed with choices, tends to focus on superficial criteria like height, weight, and physical appearance, which are not reliable indicators of relationship compatibility. Prioritising these criteria can lead to transient relationships and significant disillusionment. This was further substantiated by a 2017 study from Harvard University, which found that those who prioritise physical attractiveness are often quick to abandon their current relationships in search of new ones.

Another pitfall of digital dating is the inadvertent idealisation of potential partners. In face-to-face interactions, nuances like voice, smell, gestures, and humour play a pivotal role in forming impressions. In stark contrast, online platforms offer limited information, which could be a brief bio or a favourite song. Such limited data impedes the formation of a well-rounded perception of the other person, leading users to fill in the gaps with optimistic assumptions, often attributing positive traits or qualities of close friends to the person they’re communicating with online. The inevitable real-life meeting then becomes a breeding ground for disappointment when these augmented expectations meet reality.

Furthermore, the veil of online anonymity paves the way for dishonesty. It’s not uncommon for users to tweak certain details about themselves to appear more appealing. Women might inaccurately report their weight, while men might exaggerate their height or other physical attributes. Such falsehoods, while potentially increasing initial interest, form a shaky foundation for building genuine, long-term relationships. If discrepancies between one’s online profile and real-life persona are noticed, it can jeopardise the trust and warmth of a budding relationship.

Adding to the list of adverse impacts, these platforms can be a significant source of emotional distress. As Moore (2022) highlights, continuous unsuccessful searches on platforms like Tinder and Bumble can lead to feelings of inadequacy, anxiety, and even depression. The impersonal nature of online interactions further exacerbates this, making genuine connection even more elusive. And while these platforms are heralded as convenient tools for those leading busy lives, like university students, they can also become a breeding ground for insincerity and malicious intent. Older men might pose with decades-old pictures, while others might push for intimate encounters prematurely, adding a layer of risk and discomfort for users.

As the digital age continues to reshape the landscape of human interaction, it becomes essential to critically appraise the profound influence of social networks and dating apps on society’s quest for genuine connections. On the surface, the convenience, extensive choices, and ease of communication these platforms offer might seem like significant advancements in the realm of romance. However, a deeper evaluation reveals potential pitfalls and challenges. With an abundance of options available through these platforms, there’s an increased tendency for individuals to approach romantic pursuits as transactional experiences, leading to feelings of dissatisfaction and a lack of commitment. The format of these platforms can result in the idealisation of potential partners, setting unrealistic expectations that are rarely met in real-life encounters.

Deceit and misrepresentation on these platforms threaten the foundation of trust, which is crucial for lasting relationships. Moreover, the emotional challenges these platforms can introduce, evidenced by the onset of issues like anxiety and depression, are concerning. The impersonal nature of virtual communication, combined with the occasional malicious intents of users, can make the online dating experience fraught with emotional pitfalls.

Additionally, the commodification of romance, where apps can sometimes become mere tools for fleeting physical encounters, further distances users from the essence of genuine, deep connections. In the vast narrative of human experience, forming and nurturing authentic relationships stand as central aspects. While dating apps and social networks offer a convenient and seemingly expansive avenue for finding potential partners, they are riddled with pitfalls that can adversely affect the very essence of romantic relationships. It’s essential for users to approach these platforms with a blend of optimism and caution, recognising that finding a meaningful connection requires more than just swiping right.

Links

https://www.insider.com/guides/health/sex-relationships/how-social-media-affects-relationships

https://www.mindbodygreen.com/articles/social-media-and-relationships

https://turbofuture.com/internet/How-SocialMedia-Relationships

The Intersection of Artificial Intelligence and Neurobiology

First published 2023

In the evolving field of artificial intelligence, a groundbreaking study by researchers at the University of Cambridge has unveiled a new facet of AI development. This research reveals how an AI system can self-organise to develop characteristics similar to the brains of complex organisms. Based on the concept of imposing physical and biological constraints on an AI system, similar to those experienced by the human brain, this study marks a significant step in understanding the complex balance between the development, operation, and resource optimisation of neural systems.

The human brain, renowned for its ability to solve complex problems efficiently and with minimal energy, serves as a model for this innovative AI system. By mimicking the brain’s organisational structure and learning mechanisms, the Cambridge scientists have opened new pathways in AI research. Their work focuses on creating an artificial neural network that not only resembles the human brain in functionality but also adheres to similar physical limitations, thereby offering insights into both the evolution of biological brains and the advancement of artificial intelligence.

Contact

The study, published in Nature Machine Intelligence, highlights the intersection of neurobiology and AI, demonstrating how an understanding of the human brain can inspire and guide the development of more efficient, human-like AI systems. The findings from this research are particularly relevant in the context of designing AI systems and robots that must operate within the constraints of the physical world, balancing the need for information processing with energy efficiency. This revolves around the principle of imposing physical constraints on an AI system, similar to the constraints faced by the human brain. These constraints include the need to develop and operate within physical and biological boundaries while balancing energy and resource demands for growth and network sustainability.

The artificial system developed by the research team was designed to emulate a simplified version of the brain, using computational nodes similar to neurons in function. These nodes were placed in a virtual space, with their communication ability dependent on their proximity, mirroring the organisation of neurons in the human brain. The system was tasked with a maze navigation challenge, a task often used in brain studies involving animals. As the AI system attempted the task, it adapted by altering the strength of connections between its nodes, a process analogous to learning in the human brain.

A key observation was the system’s response to physical constraints. The difficulty in forming connections between distant nodes led to the development of highly connected hubs, similar to the human brain. Additionally, the system demonstrated a flexible coding scheme, where individual nodes could encode multiple aspects of the maze task, reflecting another feature of complex brains.

Over time, the AI system developed by the Cambridge team demonstrated a remarkable evolution, mirroring the adaptive processes observed in biological brains. This adaptation was primarily driven by the system’s need to balance its finite resources while optimising its intra-network communication for efficient signal propagation. As the system learned and evolved, it began to exhibit structural and functional characteristics similar to those of biological brains. This included the development of modular small-world networks, characterised by dense connectivity within modules and sparse connections between them, facilitating efficient information processing.

This evolutionary process also saw the system refine its connections, selectively pruning those that were less contributory to signal propagation, a feature also characteristic of biological neural networks. Notably, the system’s neurons adapted to optimise both their structural and functional objectives in real time. This dynamic trade-off between different objectives led to an increasingly efficient network that could solve complex tasks with high accuracy. As the system continued to learn, it showed a decrease in average connectivity strength, particularly by pruning long-distance connections, further enhancing its efficiency and replicating another aspect of empirical brain networks across species and scales. This ongoing evolution of the system’s structure and function underlines its remarkable ability to adapt and improve its efficiency in solving tasks, much like the human brain.

The significance of these findings lies not only in their contribution to our understanding of the human brain but also in their potential applications in AI development. The study suggests that AI systems tackling human-like problems may ultimately resemble the structure of an actual brain, especially in scenarios involving physical constraints. This resemblance could be crucial for robots operating in the real world, needing to process changing information and control their movements efficiently within energy limitations.

The emergence of modular small-world networks within the Cambridge team’s AI system is a significant aspect of its evolution, reflecting key characteristics commonly observed in empirical brain networks. Modularity in this context refers to the formation of densely interconnected nodes within a specific module, contrasted with weaker and sparser connections between different modules. Small-worldness, on the other hand, indicates a network where any pair of nodes is connected through a short path, yet there is high local clustering. When local biophysical constraints were imposed on the system, both modularity and small-worldness were enhanced in the spatially embedded recurrent neural networks (seRNNs). This development meant that the seRNNs began to mirror the topological features seen in biological brain networks, with increased modularity and small-world characteristics compared to baseline networks (L1 networks) over the course of training. These developments are crucial in understanding how the system adapts to optimise its structure for efficient information processing.

The research represents a pivotal moment in the intersection of artificial intelligence and neurobiology. By demonstrating that AI systems can develop brain-like features under physical constraints, this study not only deepens our understanding of the human brain’s organisation but also paves the way for more efficient and sophisticated AI architectures. The implications of this research extend far beyond the academic sphere, potentially influencing future AI applications in various fields, including robotics and cognitive computing.

In the broader context, this study underscores the importance of interdisciplinary approaches in advancing AI. The convergence of insights from neurobiology, computer science, and engineering in this research highlights the potential for collaborative efforts to yield transformative breakthroughs. As AI continues to evolve, the lessons learned from the human brain’s efficient and adaptive nature could inform the design of AI systems that are more capable of tackling complex, real-world problems within the constraints of limited resources.

Moreover, the findings of this study have significant implications for the development of AI systems in areas where energy efficiency and adaptability are crucial. This includes autonomous systems and robots operating in dynamic environments, where the ability to process vast amounts of information efficiently is vital. The research suggests that AI systems that more closely resemble the structure and function of the human brain could offer superior performance in such scenarios.

In conclusion, the Cambridge team’s research marks a significant advancement in the development of AI systems that not only mimic human cognitive abilities but also emulate the brain’s remarkable efficiency and adaptability. The system’s development under constraints has led to the formation of structures and functions that closely mirror those of the human brain. This breakthrough in AI design offers profound insights into the brain’s organisation and guides the development of advanced AI systems capable of replicating complex brain-like functionalities. This study not only enriches our understanding of the brain’s organisational principles but also offers a blueprint for the future of AI development, where systems are not just intelligent but also resource-conscious and adaptable, much like the brains they seek to emulate.

Links

Achterberg, J., Akarca, D., Strouse, D.J. et al. Spatially embedded recurrent neural networks reveal widespread links between structural and functional neuroscience findings. Nat Mach Intell (2023). https://doi.org/10.1038/s42256-023-00748-9

https://www.cam.ac.uk/research/news/ai-system-self-organises-to-develop-features-of-brains-of-complex-organisms

Social Prescribing in the NHS: Challenges, Impact, and Future Directions

First published 2023

Social prescribing has emerged as a pivotal element in NHS England’s long-term strategy, reflecting a commitment to more personalised care and the reduction of health disparities. This approach involves referring patients to link workers, who then connect them with community-based services to address their non-medical needs. This initiative, integral to the NHS’s objective, seeks to foster a more comprehensive understanding of patient care, transcending traditional medical interventions. The emphasis on holistic care within this framework is noteworthy, as it signifies a shift towards viewing patient health through a wider lens, encompassing not just physical ailments but also the social, emotional, and environmental factors that contribute to a person’s overall wellbeing. In this context, social prescribing stands not just as a service, but as a reflection of a broader paradigm shift in healthcare, where the focus is on treating the individual as a whole rather than just addressing isolated health issues.

In 2019, NHS England made a significant commitment to social prescribing, recognising its potential in transforming patient care. This commitment involved the funding of link workers for each of England’s 1300 Primary Care Networks, a move that underscored the NHS’s dedication to integrating social prescribing into mainstream healthcare. These link workers are tasked with connecting patients to community-based services, addressing a range of non-medical needs that significantly impact health and wellbeing. However, the journey of integrating social prescribing into the NHS has not been without its challenges. Research on the implementation and impact of social prescribing has been both limited and inconclusive, marked by methodological challenges. Many studies evaluating social prescribing have suffered from issues such as small participant numbers, weak design structures, lack of control groups, and short durations, which have all contributed to a lack of robust evidence supporting its efficacy. Despite these challenges, the NHS’s investment in social prescribing represents a forward-thinking approach to healthcare, aiming to address the wider determinants of health in a more comprehensive manner.

Contact

In the NHS, the roles and responsibilities of social prescribers are integral to the broader vision of patient-centered care. General practice staff play a crucial role in this model by identifying patients who could benefit from social prescribing and referring them to link workers. These link workers, a vital cog in the system, are responsible for bridging the gap between clinical healthcare and community-based support services. They connect patients with various non-medical resources and services, which can range from social and community activities to practical assistance, addressing a diverse spectrum of patient needs that often fall outside the scope of traditional medical care.

However, one of the challenges faced in the realm of social prescribing within the NHS is the lack of a standardised approach for assessing social needs. Unlike some other healthcare models where structured and formalised assessments are the norm, the NHS encourages link workers to adopt a more holistic and individualised approach to assess patients. They are guided to ask open-ended questions, focusing on ‘what matters’ to the patient, rather than adhering to a rigid, standardised assessment protocol. This approach aims to capture a broader understanding of the patient’s life, their challenges, and their aspirations. Despite its patient-centred nature, this lack of standardisation in assessments can lead to challenges in tracking and systematically addressing the population-level social needs, thereby highlighting a key area for potential improvement in the practice of social prescribing.

Social prescribing serves as a significant intervention in addressing some of the key social determinants of health that profoundly affect patients’ lives. By focusing on areas such as housing, finances, and employment, social prescribing addresses the major drivers of referrals, going beyond the conventional scope of medical care. This approach acknowledges that health is influenced by a range of social, economic, and environmental factors, and seeks to provide support in these areas. For example, a patient struggling with financial instability or poor housing conditions may experience exacerbated health issues. Social prescribing intervenes by connecting such individuals to appropriate resources, thereby potentially alleviating stressors that contribute to poor health outcomes.

However, the complexity of social prescribing programmes presents significant challenges, particularly when it comes to evaluating their effectiveness through randomised control trials (RCTs). These challenges arise from the multifaceted and personalised nature of the interventions, which are tailored to individual needs and local contexts. This variability makes it difficult to apply the standardisation typically required in RCTs, hindering the ability to produce generalised conclusions about the effectiveness of social prescribing. Moreover, the human and community elements integral to social prescribing defy easy quantification, further complicating efforts to measure outcomes in a manner that satisfies the rigorous criteria of traditional clinical research. Therefore, while the potential benefits of social prescribing to patients are considerable, there remains a need for innovative research methodologies that can capture the true impact of these complex interventions.

Social prescribing significantly contributes to the holistic care of patients by addressing a broad spectrum of social and non-medical needs that are integral to overall health and wellbeing. This approach recognises that health is not solely determined by medical factors, but also by a range of social, environmental, and economic factors. By connecting patients with community resources and services, social prescribing endeavours to improve aspects of their lives that medical treatments alone cannot address. This could include facilitating access to social support groups, financial advice, or housing services, thereby catering to the multifaceted nature of individual health.

The diverse and personalised nature of social prescribing, however, underscores the need for a robust evaluation framework. Such a framework is essential to develop a common body of knowledge on the effectiveness and impact of social prescribing. The current landscape, characterised by varied methodologies and a lack of standardisation in assessment and implementation, hinders the ability to comprehensively understand and quantify the benefits of social prescribing. An effective evaluation framework would enable better comparison across different programs, facilitate the identification of best practices, and contribute to the continuous improvement of social prescribing services. Establishing this framework is pivotal for substantiating the role of social prescribing in holistic patient care and for ensuring its effective integration into broader healthcare systems.

The implementation of social prescribing within the healthcare system, while innovative and promising, faces significant challenges, particularly in conducting methodologically rigorous studies. The intrinsic complexity and individualised nature of social prescribing make it difficult to apply traditional research methodologies, like randomised control trials, which are the gold standard in clinical research. These challenges stem from the highly personalised approach of social prescribing, where interventions are tailored to the unique social and environmental contexts of each patient. Consequently, there is a growing recognition of the need for more adaptable and context-sensitive research methods. Pragmatic trials and quasi-experimental study designs are being considered in the UK as viable alternatives. These approaches could provide more practical insights into the effectiveness of social prescribing by capturing real-world complexities and variations in implementation.

Another significant area of concern is the impact of social prescribing on the voluntary sector. The integration of social prescribing into healthcare systems raises questions about the capacity and sustainability of community-based organizations (CBOs) and voluntary services. There are worries that these organisations might face overwhelming demand due to referrals from healthcare providers, which could stretch their resources thin. Additionally, there are apprehensions about social prescribing potentially widening existing inequalities. If not carefully managed and supported, social prescribing schemes might inadvertently exacerbate disparities by funnelling resources towards more accessible or visible groups, while neglecting others who are harder to reach or less well-represented. Addressing these challenges requires a concerted effort to ensure that social prescribing is implemented in a way that is equitable, sustainable, and synergistic with the voluntary sector’s capabilities.

Critically analysing the effectiveness of social prescribing within the NHS involves examining its targeted approach and patient outcomes. The NHS has recommended social prescribing particularly for patients with long-term conditions, mental health issues, loneliness, and those with complex social needs. This targeted approach, while ensuring resources are directed to those most in need, raises questions about its inclusivity and potential to overlook others who might also benefit from such interventions. Additionally, the debate around whether to focus on high-need, high-cost patients or to adopt a more universal screening for social risks is pivotal. It reflects a broader discussion about resource allocation and the strategic direction of healthcare services in addressing social determinants of health.

The role of new technology in social prescribing is another crucial aspect to consider. The NHS’s foray into digital tools and platforms, which facilitate referrals and connections between healthcare providers and community-based organisations, presents both opportunities and challenges. On one hand, these technologies could streamline processes, improve data collection and analysis, and potentially enhance the reach and efficiency of social prescribing programmes. On the other hand, the integration of such technologies needs careful consideration to ensure they are accessible to all patient groups, including those who may be less tech-savvy. The impact of digital tools on the patient experience and the quality of care delivered through social prescribing also warrants close examination. As technology becomes more embedded in healthcare, understanding its influence on the effectiveness of social prescribing will be crucial in shaping future strategies and policies.

The Implications of Artificial Intelligence Integration within the NHS

The future of social prescribing within the NHS is likely to be significantly influenced by ongoing reforms in payment structures and the implementation of quality measures. The shift from traditional fee-for-service models to value-based payment systems could play a pivotal role in the broader adoption of social prescribing. This transition may create financial incentives for healthcare providers to engage more actively in social prescribing, as it aligns with the overarching goal of improving population health and potentially reducing healthcare costs. The inclusion of social risk screening and the implementation of social interventions as quality measures in payment contracts could further incentivise healthcare providers to integrate social prescribing into their practice. However, the impact of these changes on the national-level adoption and effectiveness of social prescribing requires careful monitoring and research to ensure that they genuinely enhance patient care without inadvertently creating new challenges or disparities.

In addition, the efforts to coordinate social prescribing research in the UK, drawing insights from similar initiatives in the US, present an opportunity to develop more informed and effective policies. By building a more robust evidence base and sharing best practices, both countries can refine their social prescribing models to better meet the needs of their populations. This collaborative approach can facilitate the identification of successful strategies, highlight areas for improvement, and ultimately contribute to the evolution of social prescribing into a more effective and integral component of healthcare. These emerging research efforts are crucial for not only assessing the current state of social prescribing but also for shaping its future trajectory, ensuring that it remains responsive to the changing healthcare landscape and continues to address the complex needs of patients.

Looking towards the future, the evolution of social prescribing within the NHS is closely tied to ongoing changes in payment reforms and quality measures. The transition from fee-for-service to value-based payment models in the healthcare system could significantly influence the adoption of social prescribing. Such payment reforms are designed to prioritise patient outcomes and cost-effectiveness, potentially providing a financial impetus for healthcare providers to incorporate social prescribing into their practice. As quality measures increasingly include elements of social care and patient well-being, there could be a stronger push towards holistic care approaches, with social prescribing playing a key role.

Furthermore, the emerging efforts to coordinate social prescribing research in the UK, taking cues from similar endeavours in the US, are likely to have a profound impact on policy development. These efforts are critical in establishing a more comprehensive understanding of how social prescribing can be effectively implemented and scaled. Learning from the US experience, the UK can refine its approach to social prescribing, addressing gaps in current practices and identifying successful strategies that can be adapted to the UK context. As research continues to evolve, it will inform policy decisions, ensuring that social prescribing is not only well-integrated into the healthcare system but also continually assessed for its efficacy and relevance to patient needs. This coordinated research approach is essential for the continued development of social prescribing, shaping it into an increasingly effective tool for addressing the holistic needs of patients.

In conclusion, social prescribing has emerged as a significant and increasingly popular approach among UK policymakers, aiming to revolutionise patient care by addressing a wide range of social and non-medical needs. Central to NHS England’s long-term plan, this approach signifies a shift towards a more holistic understanding of health, recognising the complex interplay between social factors and individual wellbeing. Despite its growing acceptance, there remains a pressing need for more robust research to inform its implementation and impact. Challenges such as the lack of standardised assessment methods, the complexity of evaluating its effectiveness, and the strain on the voluntary sector highlight the areas requiring attention. The potential of new technologies in enhancing the reach and efficiency of social prescribing also warrants exploration. Furthermore, the influence of payment reforms and quality measures on the adoption of social prescribing is an area ripe for investigation. As efforts to coordinate research in the UK, informed by international experiences, gain momentum, they promise to guide future policy developments. Ensuring that social prescribing is effectively integrated into the healthcare system, and continuously evolves based on evidence-based practices, remains a critical goal for enhancing patient care and addressing the broader determinants of health.

The Implications of Artificial Intelligence Integration within the NHS

First published 2023

This CreateAnEssay4U special edition brings together the work of previous essays and provides a comprehensive overview of an important technological area of study. For source information, see also:

https://createanessay4u.wordpress.com/tag/ai/

https://createanessay4u.wordpress.com/tag/nhs/

The advent and subsequent proliferation of Artificial Intelligence (AI) have ushered in an era of profound transformation across various sectors. Notably, within the domain of healthcare, and more specifically within the context of the United Kingdom’s National Health Service (NHS), AI’s incorporation has engendered a myriad of both unparalleled opportunities and formidable challenges. From an academic perspective, there is a burgeoning consensus that AI might be poised to rank among the most salient and transformative developments in the annals of human progression. It is neither hyperbole nor mere conjecture to assert that the innovations stemming from AI hold the potential to redefine the contours of our societal paradigms. In the ensuing discourse, we shall embark on a rigorous exploration of the multifaceted impacts of AI within the NHS, striving to delineate the promise it holds while concurrently interrogating the potential pitfalls and challenges intrinsic to such profound technological integration.

Contact

Medical Imaging and Diagnostic Services play a pivotal role in the modern healthcare landscape, and the integration of AI within this domain has brought forth noteworthy advancements. AI’s robust capabilities for image analysis have not only enhanced the precision in diagnostics but also broadened the scope of early detection across a variety of diseases. Radiology professionals, for instance, increasingly leverage these advanced tools to identify diseases at early stages and thereby minimise diagnostic errors. Echocardiography charts, used to gauge heart patterns and detect conditions such as ischemic heart disease, are another beneficiary of AI’s analytical prowess. An example of this is the Ultromics platform from a hospital in Oxford, which employs AI to meticulously analyse echocardiography scans.

Moreover, the application of AI in diagnostics transcends cardiological needs. From detecting skin and breast cancer, eye diseases, pneumonia, to even predicting psychotic occurrences, AI’s potential in medical diagnostics is vast and promising. Neurological conditions like Parkinson’s disease can be identified through AI tools that examine speech patterns, predicting its onset and progression. In the realm of endocrinology, a study used machine learning models to foretell the onset of diabetes, revealing that a two-class augmented decision tree was most effective in predicting diabetes-associated variables.

Artificial Intelligence in Healthcare

Furthermore, the global threat of COVID-19 in 2019 also saw AI playing a crucial role in early detection and diagnosis. Numerous medical imaging tools, encompassing X-rays, CT scans, and ultrasounds, employed AI techniques to assist in the timely diagnosis of the virus. Recent studies have spotlighted AI’s efficacy in differentiating COVID-19 from other conditions like pneumonia using imaging modalities like CT scans and X-rays. The surge in AI-based diagnostic tools, such as the deep learning model known as the transformer, facilitates efficient management of COVID-19 cases by offering rapid and precise analyses. Notably, the ImageNet-pretrained vision transformer was used to identify COVID-19 cases using chest X-ray images, showcasing the adaptability and precision of AI in response to pressing global health challenges.

The Role of ArtificiaI Intelligence in Revolutionising Radiology

Moreover, advancements in AI aren’t limited to diagnostic models alone. The field has seen the emergence of tools like Generative Adversarial Networks (GANs), which have considerably influenced radiological practices. Comprising a generator that produces images mirroring real ones, and a discriminator that differentiates between the two, GANs have the potential to redefine radiological operations. Such networks can replicate training images and create new ones with the training dataset’s characteristics. This technological advancement has not only aided in tasks like abnormal detection and image synthesis but has also posed challenges even for experienced radiologists, as discerning between GAN-generated and real images becomes increasingly intricate.

Education and research also stand to benefit immensely from such advancements. GANs have the potential to swiftly generate training material and simulations, addressing gaps in student understanding. As an example, if students struggle to differentiate between specific medical conditions in radiographs, GANs could produce relevant samples for clearer understanding. Additionally, GANs’ capacity to model placebo groups based on historical data can revolutionise clinical trials by minimising costs and broadening the scope of treatment arms.

Revolutionising Patient Data: The Role of Coding and AI in the NHS

Furthermore, the role of AI in offering virtual patient care cannot be overstated. In a time where in-person visits to medical facilities posed risks, AI-powered tools bridged the gap by facilitating remote consultations and care. Moreover, the management of electronic health records has been vastly streamlined due to AI, reducing the administrative workload of healthcare professionals. It’s also reshaping the dynamics of patient engagement, ensuring they adhere to their treatment plans more effectively.

The NHS Digital Clinical Safety Strategy: Towards Safer and Digitally Enabled Care

The impact of AI on healthcare has transcended beyond diagnostics, imaging, and patient care, making significant inroads into drug discovery and development. AI-driven technologies, drawing upon machine learning, bioinformatics, and cheminformatics, are revolutionising the realm of pharmacology and therapeutics. With the increasing challenges and sky-high costs associated with drug discovery, these technologies streamline the processes and drastically reduce the time and financial investments required. Historical precedents, like the AI-based robot scientist named Eve, stand as a testament to this potential. Eve not only accelerated the drug development process but also ensured its cost-effectiveness.

AI’s capabilities are not just confined to the initial phase of scouting potential molecules in the field of drug discovery. There’s a promise that AI could engage more dynamically throughout the drug discovery continuum in the near future. The numerous AI-aided drug discovery successes in the literature are a testament to this potential. A notable instance is the work by Toronto-based firm, deep genomics. Harnessing the power of an AI workbench platform, they identified a novel genetic target and consequently developed the drug candidate DG12P1, aimed at treating a rare genetic variant of Wilsons’ disease.

AI-Powered Precision Medicine: Tailoring Healthcare to the Individual Genome

One of the crucial aspects of drug development lies in identifying novel drug targets, as this could pave the way for pioneering first-in-class clinical drugs. AI proves indispensable here. It not only helps in spotting potential hit and lead compounds but also facilitates rapid validation of drug targets and the subsequent refinement in drug structure design. Another noteworthy application of AI in drug development is its ability to predict potential interactions between drugs and their targets. This capability is invaluable for drug repurposing, enabling existing drugs to swiftly progress to subsequent phases of clinical trials.

Moreover, with the data-intensive nature of pharmacological research, AI tools can be harnessed to sift through massive repositories of scientific literature, including patents and research publications. By doing so, these tools can identify novel drug targets and generate innovative therapeutic concepts. For effective drug development, models can be trained on extensive volumes of scientific data, ensuring that the ensuing predictions or recommendations are rooted in comprehensive research.

The Use of Machine Learning Models in Healthcare

Furthermore, AI’s applications aren’t just limited to drug discovery and design. It’s making tangible contributions in drug screening as well. Numerous algorithms, such as extreme learning machines, deep neural networks (DNNs), random forests (RF), support vector machines (SVMs), and nearest-neighbour classifiers, are now at the forefront of virtual screening. These are employed based on their synthesis viability and their capacity to predict in vivo toxicity and activity, thereby ensuring that potential drug candidates are both effective and safe.

The De-Skilling of the Workforce by Artificial Intelligence in the UK

The proliferation of AI in various sectors has brought along with it a range of ethical and social concerns that intersect with broader questions about technology, data usage, and automation. Central among these concerns is the question of accountability. As AI systems become more integrated into decision-making processes, especially in sensitive areas like healthcare, who is held accountable when things go wrong? The possibility of AI systems making flawed decisions, often due to intrinsic biases in the datasets they are trained on, can lead to catastrophic outcomes. An illustration of such a flaw was observed in an AI application that misjudged pneumonia-related complications and potentially jeopardised patients’ health. These erroneous decisions, often opaque in nature due to the intricate inner workings of machine learning algorithms, further fuel concerns about transparency and accountability.

Ethical and Practical Dimensions of Big Data in the NHS

Transparency, or the lack thereof, in AI systems poses its own set of challenges. As machine learning models continually refine and recalibrate their parameters, understanding their decision-making process becomes elusive. This obfuscation often referred to as the ‘black-box’ phenomenon, hampers trust and understanding. The branch of AI research known as “Explainable Artificial Intelligence (XAI)” attempts to remedy this by making the decision-making processes of AI models understandable to humans. Through XAI, healthcare professionals and patients can glean insights into the rationale behind diagnostic decisions made by AI systems. Furthermore, this enhances the trust quotient, as evidenced by studies that underscore the importance of visual feedback in fostering trust in AI models.

Artificial Intelligence in Healthcare: Boon or Bane?

Another prominent concern is the potential reinforcement of existing societal biases. AI systems, trained on historically accumulated data, can inadvertently perpetuate and even amplify biases present in the data, leading to skewed and unjust outcomes. This is particularly alarming in healthcare, where decisions can be a matter of life and death. This threat is further compounded by data privacy and security issues. AI systems that process sensitive patient information become prime targets for cyberattacks, risking unauthorised access or tampering of data, with motives ranging from financial gain to malicious intent.

The Exploitation of Data in AI Systems

The rapid integration of AI technologies in healthcare underscores the need for robust governance. Proper governance structures ensure that regulatory, ethical, and trust-related challenges are proactively addressed, thereby fostering confidence and optimising health outcomes. On an international level, regulatory measures are being established to guide the application of AI in domains requiring stringent oversight, such as healthcare. The European Union, for instance, introduced the GDPR in 2018, setting forth data protection standards. More recently, the European Commission proposed the Artificial Intelligence Act (AIA), a regulatory framework designed to ensure the responsible adoption of AI technologies, mandating rigorous assessments for high-risk AI systems.

Data Bias in Artificial Intelligence

AI in Healthcare: Navigating Biases and Inequities During COVID-19

From a technical standpoint, there are further substantial challenges to surmount. For AI to be practically beneficial in healthcare settings, it needs to be user-friendly for healthcare professionals (HCPs). The technical intricacies involved in setting up and maintaining AI infrastructure, along with concerns of data storage and validity, often act as deterrents. AI models, while potent, are not infallible. They can manifest shortcomings, such as biases or a susceptibility to being easily misled. It is, therefore, imperative for healthcare providers to strategise effectively for the seamless implementation of AI systems, addressing costs, infrastructure needs, and training requirements for HCPs.

Issues in Patient Confidentiality

The perceived opaqueness of AI-driven clinical decision support systems often makes HCPs sceptical. This, combined with concerns about the potential risks associated with AI, acts as a barrier to its widespread adoption. It is thus imperative to emphasise solutions like XAI to bolster trust and overcome the hesitancy surrounding AI adoption. Furthermore, integrating AI training into medical curricula can go a long way in ensuring its safe and informed usage in the future. Addressing these challenges head-on, in tandem with fostering a collaborative environment involving all stakeholders, will be pivotal for the responsible and effective proliferation of AI in healthcare. Recent events, such as the COVID-19 pandemic and its global implications alongside the Ukraine war, underline the pressing need for transformative technologies like AI, especially when health systems are stretched thin.

Exploring Challenges of AI Implementation in Healthcare: A Study from Sweden

Given these advancements, it is pivotal however to scrutinise the sources of this information. Although formal conflicts of interest should be declared in publications, authors may have subconscious biases, for and against, the implementation of AI in healthcare, which may influence the authors’ interpretations of the data. Discussions are inevitable regarding published research, particularly since the concept of ‘false positive findings’ came to the forefront in 2005 in a review by John Ioannidis (“Why Most Published Research Findings Are False”). The observation that journals are biased in publishing more papers that have positive rather than negative findings both skews the total body of the evidence and underscores the need for studies to be accurate, representative, and negligibly biased. When dealing with AI, where the risks are substantial, relying solely on justifiable scientific evidence becomes imperative. Studies that are used for the implementation of AI systems should be well mediated by a neutral and independent third party to ensure that any advancements in AI system implementations are based solely on justified scientific evidence, and not on personal opinions, commercial interests or political views.

The Challenges of Employing Black Box Algorithms in Healthcare

The evidence reviewed undeniably points to the potential of AI in healthcare. There is no doubt that there is real benefit in a wide range of areas. AI can enable services to be run more efficiently, allow selection of patients who are most likely to benefit from a treatment, boost the development of drugs, and accurately recognise, diagnose, and treat diseases and conditions.

The Role of Medical Statistics in Healthcare

However, with these advancements come challenges. We identified some key areas of risk: the creation of good quality big data and the importance of consent; the data risks such as bias and poor data quality; the issue of a black box (lack of transparency of algorithms); data poisoning; and data security. Workforce issues were also identified: how AI works with the current workforce and the fear of workforce replacement; the risk of de-skilling; and the need for education and training, and embedding change. It was also identified that there is a current need for research into use, cost-effectiveness, and long-term outcomes of AI systems. There will always be a risk of bias, error chance statistical improbabilities, in research and published studies fundamentally due to the nature of science itself. Yet, the aim is to have a body of evidence that helps create a consensus of opinion.

Use of Artificial Intelligence in the UK NHS

In summary, the transformative power of AI in the healthcare sector is unequivocal, offering advancements that have the potential to reshape patient care, diagnostics, drug development, and a myriad of other domains. These innovations, while promising, come hand in hand with significant ethical, social, and technical challenges that require careful navigation. The dual-edged sword of AI’s potential brings to light the importance of transparency, ethical considerations, and robust governance in its application. Equally paramount is the need for rigorous scientific evaluation, with an emphasis on neutrality and comprehensive evidence to ensure AI’s benefits are realised without compromising patient safety and care quality. As the healthcare landscape continues to evolve, it becomes imperative for stakeholders to strike a balance between leveraging AI’s revolutionary capabilities and addressing its inherent challenges, all while placing the well-being of patients at the forefront.

This CreateAnEssay4U special edition brings together the work of previous essays and provides a comprehensive overview of an important technological area of study. For source information, see also:

https://createanessay4u.wordpress.com/tag/ai/

https://createanessay4u.wordpress.com/tag/nhs/

Links

https://www.gs1ca.org/documents/digital_health-affht.pdf

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7670110/

https://www.who.int/emergencies/diseases/novel-coronavirus-2019/technical-guidance/naming-the-coronavirus-disease-(COVID-2019)-and-the-virus-that-causes-it

https://www.rcpjournals.org/content/futurehosp/9/2/113

https://doi.org/10.1016%2Fj.icte.2020.10.002

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9151356/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7908833/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8285156/

https://pubmed.ncbi.nlm.nih.gov/32665978

https://doi.org/10.1016%2Fj.ijin.2022.05.002

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8669585/

https://scholar.google.com/scholar_lookup?journal=Med.+Image+Anal.&title=Transformers+in+medical+imaging:+A+survey&author=F.+Shamshad&author=S.+Khan&author=S.W.+Zamir&author=M.H.+Khan&author=M.+Hayat&publication_year=2023&pages=102802&pmid=37315483&doi=10.1016/j.media.2023.102802&

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8421632/

https://www.who.int/docs/defaultsource/documents/gs4dhdaa2a9f352b0445bafbc79ca799dce4d.pdf

https://www.bbc.com/news/health-42357257

https://www.ibm.com/blogs/research/2017/1/ibm-5-in-5-our-words-will-be-the-windows-to-our-mental-health/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10057336/

https://doi.org/10.48550%2FarXiv.2110.14731

https://journals.plos.org/plosmedicine/article?id=10.1371/journal.pmed.0020124

https://scholar.google.com/scholar_lookup?journal=Proceedings+of+the+IEEE+15th+International+Symposium+on+Biomedical+Imaging&title=How+to+fool+radiologists+with+generative+adversarial+networks?+A+visual+turing+test+for+lung+cancer+diagnosis&author=M.J.M.+Chuquicusma&author=S.+Hussein&author=J.+Burt&author=U.+Bagci&pages=240-244&

https://pubmed.ncbi.nlm.nih.gov/23443421

https://www.nuffieldbioethics.org/assets/pdfs/Artificial-Intelligence-AI-in-healthcare-and-research.pdf

https://link.springer.com/article/10.1007/s10916-017-0760-1

Polypharmacy in the Aging Population: Balancing Medication, Humanity, and Care

First published 2023

Polypharmacy, the concurrent use of multiple medications by a patient, has become increasingly prevalent, especially among older adults. As societies worldwide witness a surge in their aging populations, the issue of polypharmacy becomes even more pressing. In many countries, a significant portion, often exceeding 20%, of the population is aged 65 and above. This demographic shift has several implications, not the least of which is the complex and multifaceted issue of medication management.

Women, who constitute a majority of the elderly population, become even more predominant as age advances. This gender skew in the older demographic is vital to consider, especially when discussing drug safety. Older women might face heightened susceptibility to drug-related harm compared to their male counterparts. Such vulnerabilities can arise from pharmacokinetic and pharmacodynamic changes. These distinctions emphasise the necessity of tailoring medication regimes to accommodate these differences, making medication optimisation for older women a priority.

Contact

The ramifications of polypharmacy extend beyond the individual. The risks associated with polypharmacy, which include inappropriate or unsafe prescribing, can be profoundly detrimental. Recognizing these dangers, the World Health Organization (WHO) initiated the “Medication Without Harm” campaign as its third Global Patient Safety Challenge. Launched in 2017, this initiative seeks to halve avoidable medication harm over a span of five years. Its inception underscores the global nature of the polypharmacy issue and the consequent need for concerted, international attention.

Deprescribing, a strategy centered on judiciously reducing or discontinuing potentially harmful or unnecessary medications, emerges as a crucial countermeasure to polypharmacy’s perils. Implementing a systematic approach to deprescribing can not only improve an older individual’s quality of life but also significantly decrease the potential for drug-related harm. This is particularly relevant for older women, emphasising once again the need to incorporate sex and gender considerations into prescribing and deprescribing decisions.

While much of the research and initiative focus has been directed towards high-income countries, the principles of safe medication prescribing are universally relevant. The interaction between biological (sex) and sociocultural (gender) factors plays a pivotal role in determining medication safety. Understanding and accounting for these nuances can greatly enhance the process of prescribing or deprescribing medications for older adults. For clinicians to truly optimise the care of their older patients, a holistic approach to medication review and management is essential. Such an approach not only emphasises the individual’s unique needs and vulnerabilities but also incorporates broader considerations of sex and gender, ensuring a comprehensive and informed decision-making process.

The intricacies of polypharmacy and its management, especially in older adults, bring to light the broader challenges facing our healthcare system. As the elderly population grows, so does the prevalence of chronic diseases. These ailments often necessitate multiple medications for management and symptom relief. Consequently, the line between therapeutic benefit and potential harm becomes blurred. The balance between ensuring the effective management of various health conditions while avoiding medication-induced complications is a tightrope that clinicians must walk daily.

Deprescribing is not just about reducing or stopping medications; it’s about making informed decisions that prioritise the patient’s overall well-being. This involves a thorough understanding of each drug’s purpose, potential side effects, and how they interact with other medications the patient might be taking. But beyond that, it also demands an in-depth conversation between the patient and the healthcare provider. Patients’ beliefs, concerns, and priorities must be integral to the decision-making process. This collaborative approach ensures that the process of deprescribing respects the individual’s values and desires, moving away from a solely clinical standpoint to one that incorporates patient autonomy and quality of life.

Furthermore, the integration of technology and data analytics can play a significant role in enhancing medication safety. Electronic health records, when used effectively, can offer a comprehensive view of a patient’s medication history, allowing clinicians to identify potential drug interactions or redundancies. Predictive analytics, fed with vast amounts of data, might also identify patients at high risk for drug-related harms, thereby aiding in early interventions. The digital age, with its myriad tools, has the potential to revolutionise the way we approach polypharmacy, offering more precise, personalised, and proactive care.

However, while technology can assist, it cannot replace the fundamental human elements of care — empathy, understanding, and communication. The process of deprescribing, or even the decision to continue a medication, often involves deep emotional and psychological dimensions for patients. Fear of relapsing into illness, concerns about changing what seems to be working, or even the symbolic acknowledgment of aging and frailty can be profound considerations for many. Clinicians must be attuned to these subtleties, approaching each case with sensitivity and a genuine commitment to understanding the person behind the patient.

Moreover, education and continuous training are pivotal. Healthcare professionals must stay updated on the latest research, guidelines, and best practices related to medication management in older adults. This not only pertains to the intricacies of pharmacology but also to the soft skills of patient communication, shared decision-making, and ethical considerations. A well-informed and compassionate healthcare provider is a cornerstone of safe and effective medication management.

In conclusion, addressing the challenges of polypharmacy in an aging global population requires a multi-faceted approach. While the scientific and technical aspects are undeniably crucial, the human elements — understanding, collaboration, and compassion — remain at the heart of optimal care. As we navigate the complexities of medication management, it is essential to remember that at the centre of every decision is an individual, with their hopes, fears, and aspirations. Prioritising their holistic well-being, informed by both science and humanity, is the ultimate goal.

Links

https://www.who.int/news-room/fact-sheets/detail/ageing-and-health

https://www.who.int/publications/i/item/WHO-HIS-SDS-2017.6

https://assets.publishing.service.gov.uk/government/uploads/system/uploads/attachment_data/file/1019475/good-for-you-good-for-us-good-for-everybody.pdf

https://www.agedcarequality.gov.au/news-centre/newsletter/quality-bulletin-36-december-2021

https://www.nia.nih.gov/news/dangers-polypharmacy-and-case-deprescribing-older-adults

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9450314/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4239968/

https://bmcgeriatr.biomedcentral.com/articles/10.1186/s12877-022-03408-6

Navigating the Complex Landscape of AI-Augmented Labour

First published 2023

Artificial intelligence (AI) has transformed the world, automating tedious tasks and pioneering breakthroughs in various sectors like healthcare. This rapid transformation promises unprecedented productivity boosts and avenues for innovation. However, as AI integrates deeper into the fabric of our daily lives, it has become evident that its benefits are not distributed evenly. Its impact could exacerbate existing social and economic disparities, particularly across demographics like race, making the dream of an equitable AI future elusive.

Today, many aspects of our lives, ranging from mundane tasks to critical decision-making in healthcare, benefit from AI’s potential. But the growing chasm of inequality resulting from AI’s penetration has sparked concerns. Business and governmental leaders are under mounting pressure to ensure AI’s advantages are universally accessible. Yet, the challenges seem to evolve daily, leading to a piecemeal approach to solutions or, in some instances, no solutions at all. Addressing AI-induced inequalities necessitates a proactive, holistic strategy.

Contact

A recent survey highlighted this division starkly. Out of the participants, 41% identified as “AI Alarmists”, those who harbour reservations about AI’s encroachment into the workplace. On the other hand, 31% were “AI Advocates” who staunchly support AI’s incorporation into labour. The remaining 28% were “AI Agnostics”, a group that views AI’s integration with balanced optimism and skepticism. Even though these figures originate from a limited online survey, they underscore the absence of a singular mindset on AI’s value in labour. The varying perspectives on the uses and users of AI provide a glimpse into the broader societal evaluations, which the researchers aim to examine further in upcoming studies.

To pave the path for a more equitable AI future, policymakers and business leaders must first identify the underlying forces propelling AI-driven inequalities. A comprehensive framework that captures these forces is proposed while emphasising the intricate social mechanisms through which AI both creates and perpetuates disparity. This approach offers twofold advantages: it’s versatile enough to be applicable across varied contexts, from healthcare to art, and it sheds light on the often-unseen ways AI impacts the demand for goods and services, a crucial factor in the spread of inequality.

Algorithmic bias epitomises the technological forces. It arises when decision-making algorithms perpetually disadvantage certain groups. The implications of such biases can be disastrous, especially in critical sectors like healthcare, criminal justice, and credit scoring. Currently, natural language processing AI (reading written text and interpreting it for coding) can be a specific cause of unconscious biases in AI systems. For example, it can process medical documents and then code it as data that is then used to make inferences from large datasets. If an AI system interprets medical notes where there are well established human biases (such as disproportionate recording of particular questions), for example, towards African American or LGBTQ+ patients, the AI could then generate a link between these characteristics. These real-world biases will then be silently reinforced and multiplied, which could lead to systematic racial and homophobic biases in the AI system.

AI’s effects on supply and demand also intricately contribute to inequality. On the supply side, AI’s potential to automate and augment human labour can significantly reduce the costs of delivering some services and products. However, as research suggests, certain jobs, especially those predominantly held by Black and Hispanic workers, are more susceptible to automation.

On the demand side, AI’s integration into various professions affects people’s valuation of those services. Research indicates that professionals advertising AI-augmented services might be perceived as less valuable or less skilled.

A metaphor that aptly describes this scenario is a tripod. If one leg (force) is deficient, it destabilises the entire structure, compromising its function and value. For a truly equitable AI future, all forces must be robust and well-balanced.

Rectifying these disparities requires multifaceted strategies. Platforms offering AI-generated services should educate consumers about AI’s complementary role, emphasising that it enhances rather than replaces human expertise. While addressing algorithmic biases and automation’s side effects is vital, these efforts alone won’t suffice. Achieving an era where AI uplifts and equalises requires stakeholders – from industries to governments and scholars – to collaboratively devise strategies that champion human-centric and equitable AI benefits.

In summation, the integration of AI into various sectors, from healthcare to graphic design, promises immense potential. However, it’s equally essential to address the challenges that arise, particularly concerning biases and public perception. As our society navigates the AI-augmented landscape, the tripod metaphor is a poignant reminder that every aspect needs equal attention and support. Rectifying algorithmic biases, reshaping perceptions, and fostering collaboration between sectors are crucial steps towards a more inclusive and equitable AI future. Embracing these facets will not only unlock AI’s full potential but also ensure its harmonious coexistence with human expertise, leading us towards a future that benefits all.

Links

https://www.pewresearch.org/science/2023/02/22/60-of-americans-would-be-uncomfortable-with-provider-relying-on-ai-in-their-own-health-care/

Algorithmic Bias in Health Care Exacerbates Social Inequities — How to Prevent It

Quantum Computing: Unlocking the Complexities of Biological Sciences

First published 2023

Quantum computing is positioned at the cutting-edge juncture of computational science and biology, promising revolutionary solutions to complex biological problems. The intertwining of advanced experimentation, theoretical advancements, and increased computing prowess have traditionally powered our understanding of intricate biological phenomena. As the demand for more robust computing infrastructure increases, so does the search for innovative computing paradigms. In this milieu, quantum computing (QC) emerges as a promising development, especially given the recent strides in technological advances that have transformed QC from mere academic intrigue to concrete commercial prospects. These advancements in QC are supported and encouraged by various global policy initiatives, such as the US National Quantum Initiative Act of 2018, the European Quantum Technologies Flagship, and significant efforts from nations like the UK and China.

Contact

At its core, quantum computing leverages the esoteric principles of quantum mechanics, which predominantly governs matter at the molecular scale. Particles, in this realm, manifest dual characteristics, acting both as waves and particles. Unlike classical computers, which use randomness and probabilities to achieve computational outcomes, quantum computers operate using complex amplitudes along computational paths. This introduces a qualitative leap in computing, allowing for the interference of computational paths, reminiscent of wave interference. While building a quantum computer is a daunting task, with current capabilities limited to around 50-100 qubits, their inherent potential is astounding. The term “qubit” designates a quantum system that can exist in two states, similar to a photon’s potential path choices in two optical fibres. It is this scalability of qubits that accentuates the power of quantum computers.

A salient feature of quantum computation is the phenomenon of quantum speedup. Simplistically, while both quantum and randomised computers navigate the expansive landscape of possible bit strings, the former uses complex-valued amplitudes to derive results, contrasting with the addition of non-negative probabilities employed by the latter. Determining the instances and limits of quantum speedup is a subject of intensive research. Some evident advantages are in areas like code-breaking and simulating intricate quantum systems, such as complex molecules. The continuous evolution in the quantum computing arena, backed by advancements in lithographic technology, has resulted in more accessible and increasingly powerful quantum computers. Challenges do exist, notably the practical implementation of quantum RAM (qRAM), which is pivotal for many quantum algorithms. However, a silver lining emerges in the form of intrinsically quantum algorithms, which are designed to leverage quintessential quantum features.

The potential applications of quantum computing in biology are vast and multifaceted. Genomics, a critical segment of the biological sciences, stands to gain enormously. By extrapolating recent developments in quantum machine learning algorithms, it’s plausible that genomics applications could soon benefit from the immense computational power of quantum computers. In neuroscience, the applications are expected to gravitate toward optimisation and machine learning. Additionally, quantum biology, which probes into chemical processes within living cells, presents an array of challenges that could be aptly addressed using quantum computing, given the inherent quantum nature of these processes. However, uncertainties persist regarding the relevance of such processes to higher brain functions.

In summation, while the widespread adoption of powerful, universal quantum computers may still be on the horizon, history attests to the fact that breakthroughs in experimental physics can occur unpredictably. Such unforeseen advancements could expedite the realisation of quantum computing’s immense potential in tackling the most pressing computational challenges in biology. As we venture further into this quantum age, it’s evident that the fusion of quantum computing and biological sciences could redefine our understanding of life’s most intricate mysteries.

Links

https://www.nature.com/articles/s41592-020-01004-3

https://ts2-space.webpkgcache.com/doc/-/s/ts2.space/en/decoding-the-quantum-world-of-biology-with-artificial-intelligence/

The De-Skilling of the Workforce by Artificial Intelligence in the UK

First published 2023

The rapid advancement of technology has brought about profound changes in various industries and professions around the world. In the UK, one of the most notable developments has been the emergence of artificial intelligence (AI) systems, which are capable of performing tasks that were traditionally carried out by humans. This has sparked concerns regarding the potential de-skilling of the workforce in certain areas. De-skilling refers to the phenomenon where individuals lose their expertise or the need for certain skills diminishes due to technological advancements. This is particularly true in areas where AI has the potential to significantly outperform human capability or where the use of AI can be more cost-effective and efficient.

Contact

A prime example of this concern can be seen in the medical field, especially in the realm of diagnostics. There is a risk that for some skills such as ECG interpretation, where there is now capacity for fully AI-led analysis, there could be a de-skilling of the workforce, as it is possible that clinicians will not be taught ECG interpretation, or keep up their current skills. The implications of this are profound. ECG interpretation, which involves analysing the electrical activity of the heart to diagnose potential abnormalities, has traditionally been a crucial skill for medical professionals. With AI systems now capable of performing this task, there’s a growing concern that future generations of doctors and medical professionals might become overly reliant on technology, potentially compromising the quality of patient care in scenarios where AI might fail or be unavailable.

However, while the fear of de-skilling is valid, there are also undeniable advantages to the AI-led analysis of ECGs. While it is arguable that the de-skilling in ECG interpretation is already happening, it is also highly likely AI interpretation of ECGs makes diagnoses of heart conditions easier and more accessible, and therefore benefits more people. With AI’s capability to process vast amounts of data quickly and identify patterns that might be overlooked by the human eye, many believe that the technology could lead to more accurate and timely diagnoses, which in turn could lead to better patient outcomes.

Outside of the medical realm, another sector in the UK that is witnessing the potential de-skilling effects of AI is the financial industry, especially in areas related to data analysis and predictions. For years, financial analysts have relied on their expertise to interpret market trends, evaluate stock performances, and make predictions for future market movements. With the advent of AI, algorithms can now process vast amounts of data at unparalleled speeds, producing forecasts and insights that can sometimes surpass human analysis in terms of accuracy and efficiency. Consequently, there’s a growing apprehension that new entrants into the financial sector may become overly dependent on these AI tools, foregoing the development of deep analytical skills and the intuitive understanding of market nuances. Such a shift could result in a workforce less equipped to think critically or creatively, especially in unprecedented market situations where historical data, and thus AI predictions based on that data, may not be as applicable. This highlights that while AI offers immense advantages in streamlining tasks and improving accuracy, it is crucial to ensure that it complements rather than replaces the indispensable human element in various professions.

In the field of manufacturing and production in the UK, the integration of AI and automation has similarly initiated discussions around the potential de-skilling of workers. Historically, manufacturing jobs have demanded a blend of technical expertise and hands-on skills, with workers often mastering detailed tasks over years of experience. Today, many of these tasks are becoming automated, with robots and AI systems taking over processes such as assembly, quality control, and even more sophisticated functions like welding or precision cutting. The efficiency and consistency offered by these machines are undeniable, but there’s growing concern that future generations of manufacturing workers might be relegated to simply overseeing machines or performing rudimentary maintenance tasks. This could result in a loss of intricate handcrafting skills, problem-solving abilities, and the nuanced understanding that comes with human touch and intuition. While automation promises enhanced productivity and potentially safer working environments, it’s essential that efforts are made to preserve the invaluable craftsmanship and expertise that have long been the hallmark of the manufacturing sector.

Furthermore, it’s essential to recognise that while AI has made significant strides in various fields, it is not infallible. In the medical field, for example, it is likely that there will always be a need for experts as AI will be unable to interpret extremely complex readings. Such situations will require human expertise, intuition, and the holistic understanding that comes with years of training and experience. In essence, while AI can augment and enhance the diagnostic process, the value of human expertise remains irreplaceable.

In conclusion, the rise of AI in the UK’s workforce brings with it both challenges and opportunities. While there are genuine concerns about the de-skilling of professionals in certain areas, it’s also important to recognise the potential benefits of these technological advancements. The key lies in striking a balance – leveraging AI’s capabilities while also ensuring that the workforce remains skilled and adept in their respective fields.

Links

https://assets.publishing.service.gov.uk/media/615d9a1ad3bf7f55fa92694a/impact-of-ai-on-jobs.pdf

https://www.consultancy.uk/news/22101/ai-to-necessitate-major-re-skilling-of-workforce

In a high-skill, high-tech economy, who is work for?

The NHS Digital Clinical Safety Strategy: Towards Safer and Digitally Enabled Care

First published 2023

Ensuring patient safety remains at the forefront of providing high-quality healthcare. Even with significant advancements in the realm of patient safety, the sobering reality is that numerous patients suffer injuries or even lose their lives due to safety issues every year. What’s even more alarming is that a staggering 83% of these harmful incidents are believed to be preventable.

Safe patient care is a complex composition created from the detailed interactions of human, technical, and systemic elements. As healthcare systems progress, healthcare professionals must continuously adapt, particularly when new digital solutions that could cause disruptions are integrated. Recognising the varied nature of this challenge, the digital clinical safety strategy, a project developed through collaboration between NHSX, NHS Digital, NHS England, and NHS Improvement, tackles the issue from two main angles. Firstly, it emphasises the critical need to ensure the intrinsic safety of the digital technologies being implemented. At the same time, these digital tools are viewed as potential answers to the current safety challenges within the healthcare sector.

Contact

In today’s digitally inclined world, certain technologies have already found widespread acceptance. Devices such as heart rate sensors, exercise trackers, and oximeters, collectively termed “wearables”, have become an integral part of our daily lives. Furthermore, the proliferation of health and fitness apps, evidenced by the fact that 1.7 billion people had downloaded one by 2018, is testament to their growing influence. Beyond assisting individuals in managing chronic conditions, these digital technologies play an indispensable role in healthcare delivery. A classic example of this is the use of electronic health records which, when combined with data mining techniques, yield valuable insights that can steer both clinical practice and policy-making.

However, as healthcare pivots towards a heavier reliance on digital means, ensuring the uninterrupted availability and unquestionable reliability of these technologies becomes paramount. It’s equally crucial that the digital interventions be tailored to match the unique preferences, needs, and digital literacy levels of individual patients, thus enhancing their overall experience.

The World Health Organization’s recent patient safety action plan has underscored the potential of digital technologies in bolstering patient safety. By improving patient access to electronic health records, we can potentially elevate the quality of care delivered, including minimising medication errors. Additionally, innovations such as artificial intelligence are making significant inroads in areas like medical imaging and precision medicine. Chatbots, another digital marvel, are transforming healthcare by providing a spectrum of services from disseminating medical information to offering mental health support.

Yet, the path to fully harnessing the power of digital technologies isn’t without its hurdles. A considerable portion of the population remains digitally disconnected, limiting their access to essential resources such as health information, education, and emerging care pathways. Furthermore, health information technology isn’t immune to glitches and can occasionally contribute to adverse patient outcomes. A study highlighting this risk found that out of 2267 patient safety incidents tied to health information technology failures in England and Wales, a significant 75% were potentially avoidable, with 18% causing direct harm to patients.

The onslaught of the covid-19 pandemic accelerated the pace of digital adoption in healthcare. In England, virtual consultations in primary care witnessed a twofold increase in the early days of the pandemic. Meanwhile, in the US, virtual appointments surged by a remarkable 154% during the last week of March 2020 when juxtaposed against the same period the previous year. These shifts, although driven by a global health emergency, hold promise for long-term benefits, encompassing improved continuity of care, cost reductions, and better clinical outcomes. Yet, the increased adoption of virtual care isn’t devoid of pitfalls. Challenges range from increased clinical uncertainties to the potential for security breaches.

The digital clinical safety strategy offers five key national action recommendations. These encompass the routine collection of information on digital clinical safety incidents, amplifying the access to and availability of digital clinical safety training, establishing a centralised digital clinical safety information hub, speeding up the adoption of digital technologies to monitor implanted medical devices, and cultivating evidence on the optimal ways to employ digital means for enhancing patient safety.

In conclusion, the recommendations encapsulated in the digital clinical safety strategy set the stage for a safer and more effective digitally enhanced healthcare future. However, success in this domain isn’t the sole responsibility of national safety leaders but demands a collaborative effort. It involves everyone, from patients and the general public to the healthcare workforce, collectively embedding a safety-first culture in healthcare. As we stand on the cusp of a digital healthcare revolution, it’s essential to remember that these recommendations are but the initial steps towards a safer, more efficient future, and frontline healthcare workers remain pivotal in bringing this vision to fruition.

Links

https://transform.england.nhs.uk/key-tools-and-info/digital-clinical-safety-strategy/

Video: Dr Minal Bakhai keynote talk from HTN Digital Primary Care

https://www.thelancet.com/journals/langlo/article/PIIS2214-109X(18)30386-3/fulltext

https://pubmed.ncbi.nlm.nih.gov/30605296/

https://kclpure.kcl.ac.uk/portal/en/publications/impact-of-ehealth-in-allergic-diseases-and-allergic-patients

https://www.who.int/teams/integrated-health-services/patient-safety/policy/global-patient-safety-action-plan

https://www.nature.com/articles/s41746-021-00418-3

https://pubmed.ncbi.nlm.nih.gov/27147516/

https://pubmed.ncbi.nlm.nih.gov/33323263/

https://pubmed.ncbi.nlm.nih.gov/32791119/

The Exploitation of Data in AI Systems

First published 2023

In the era of the Fourth Industrial Revolution, artificial intelligence (AI) stands as one of the most transformative technologies, touching almost every sector, from healthcare to finance. This revolutionary tool relies heavily on vast amounts of data, which helps train sophisticated models to make predictions, classify objects, or even diagnose diseases. However, like every technology, AI systems are not immune to vulnerabilities. As AI continues to integrate more deeply into critical systems and processes, the security of the data it uses becomes paramount.

One of the underexplored and potentially perilous vulnerabilities is the integrity of the data on which these models train. In traditional cyber-attacks, adversaries may target system infrastructure, attempting to bring down networks or steal information. But when it comes to AI, the nature of the threat evolves. Instead of simply disabling or infiltrating systems, adversaries can manipulate the very foundation upon which these systems stand: the data. This covert form of tampering, called ‘data poisoning’, presents a unique challenge because the attack is not on the system itself, but on its learning mechanism.

Contact

In essence, data poisoning corrupts the data in subtle ways that might not be immediately noticeable. When AI systems train on this tainted data, they can produce skewed or entirely incorrect outputs. This is especially concerning in sectors like healthcare, where decisions based on AI predictions can directly impact human lives. A country, large cooperation, small group, or an individual, could maliciously compromise data sources at the point of collection or processing, so that the model is trained on poisoned data, which could lead to the AI model incorrectly classifying or diagnosing patients. Imagine a scenario where medical data is deliberately tampered with to misdiagnose patients or mislead treatment plans. The repercussions could be life-threatening. As an extreme example, a large drug cooperation could poison data so that a risk score AI model would be likely to output a patient as a higher risk than they actually are. This would then enable the company to sell more drugs to those ‘High Risk’ patients.

Beyond the healthcare sector, the implications of data poisoning ripple out across various industries. In finance, maliciously altered data can result in fraudulent transactions, market manipulations, and inaccurate risk assessments. In the realm of autonomous vehicles, poisoned data might lead to misinterpretations of road scenarios, endangering lives. For the defense sector, compromised data could misinform crucial military decisions, leading to strategic failures. The breadth and depth of data poisoning’s potential impacts cannot be understated, given AI’s ubiquitous presence in modern society.

Addressing this challenge necessitates a multifaceted approach. First, there’s a need for stringent data validation protocols. By ensuring that only verified and legitimate data enters training sets, the chance of contamination decreases. Additionally, there is a need for constant vigilance and monitoring of AI systems to allow for the early detection of changes which may indicate data poisoning. Anomaly detection algorithms can be employed to scan for unusual patterns in data that might indicate tampering. Organisations should also embrace differential privacy techniques, which add a layer of noise to the data, making it difficult for attackers to reverse-engineer or poison it. Finally, continuous monitoring and retraining of AI models will ensure that they remain robust against evolving threats. By frequently updating models based on clean and recent data, any impacts of previous poisoning attacks can be mitigated.

Collaboration also stands as a potent weapon against data poisoning. By fostering a global community of AI researchers, practitioners, and policymakers, best practices can be shared, and standardised protocols can be developed. Such collaborative efforts can lead to the establishment of universally recognized benchmarks and evaluation metrics, ensuring the security and reliability of AI models irrespective of their application. Additionally, regulatory bodies must step in, imposing penalties on entities found guilty of data tampering and promoting transparency in AI deployments.

In the age of data-driven decision-making, ensuring the integrity of the information fueling our AI systems is of paramount importance. Data poisoning, while a subtle and often overlooked threat, has the potential to derail the very benefits that AI promises. By acknowledging the gravity of this issue and investing in preventive and corrective measures, society can harness the power of AI without being beholden to its vulnerabilities. As with every technological advancement, vigilance, adaptation, and collaboration will be the keys to navigating the challenges that arise, ensuring a safer and more prosperous future for all.

Links

https://www.turing.ac.uk/sites/default/files/2019-06/understanding_artificial_intelligence_ethics_and_safety.pdf

https://www.elibrary.imf.org/view/journals/087/2021/024/article-A001-en.xml

https://www.datrics.ai/articles/anomaly-detection-definition-best-practices-and-use-cases

https://www.mdpi.com/2624-800X/3/3/25

https://www.nationaldefensemagazine.org/articles/2023/7/25/defense-department-needs-a-data-centric-digital-security-organization

Exploring Challenges of AI Implementation in Healthcare: A Study from Sweden

First published 2023

The advent of artificial intelligence (AI) in healthcare promises groundbreaking advancements, from early diagnosis to personalised treatment and improved patient outcomes. However, its successful integration remains fraught with challenges. A deeper understanding of these challenges and potential solutions is necessary for the effective deployment of AI in the healthcare sector.

A Swedish research study, conducted in 2021, sought to examine these challenges. The study was based on explorative qualitative research, where individual, semi-structured interviews were conducted over an eight-month span, from October 2020 to May 2021, with 26 healthcare leaders in a regional setting. A qualitative content analysis methodology was employed, adopting an inductive approach, to extract meaningful patterns from the data.

Contact

The analysis of collected data revealed three distinct categories of challenges in the context of AI integration in healthcare. The first category, conditions external to the healthcare system, concentrated on challenges stemming from factors beyond the control of the healthcare system. These include regulatory issues, societal perceptions of AI, and various ethical concerns. The second category, capacity for strategic change management, highlighted concerns raised by leaders about the organisation’s ability to manage strategic changes effectively. Influential factors here included infrastructure readiness, technology compatibility, and the prevailing organisational culture. The third category, transformation of healthcare professions and healthcare practice, focused on the expected disruptions AI might cause in the roles and responsibilities of healthcare professionals. In this regard, leaders expressed apprehensions about potential resistance from healthcare staff, the need for retraining, and the changing nature of patient care due to the integration of AI.

Healthcare executives thereby identified numerous challenges when it comes to integrating AI both within the healthcare infrastructure and in their specific organisations. These obstacles range from external environmental factors to the intrinsic ability to manage transformative change, as well as shifts in healthcare roles and practices. The study concluded that healthcare workers can lack trust, and that the AI Systems were not well implemented, causing a reluctance in adoption of the AI. The researchers proposed the “need to develop implementation strategies across healthcare organisations to address challenges to AI-specific capacity building”.

The findings emphasise the importance of crafting strategies tailored to AI integration across healthcare institutions. Moreover, regulatory frameworks and policies should be in place to guide the proper formation and deployment of these AI strategies. Effective implementation necessitates dedicating ample time and resources, and fostering collaboration among healthcare providers, regional governing bodies, and relevant industry partners.

However, the study was not without its limitations. The reliance on just 26 healthcare professionals can be seen as a significant constraint, given the multidimensional and expansive nature of AI in healthcare. Such a limited dataset can inherently introduce biases and may not capture the broader perspective or concerns of the entire community. There is also no evidence to suggest how these 26 professionals were chosen, or whether they had any conflicts of interests. The study reports that it was conducted in one region of the country and so, any regional differences of understanding and perception AI, can cause issues when these conclusions are extrapolated to a national level. Furthermore, there are significant differences in countries’ healthcare systems globally, and so, conclusions of system perfectly fit for purpose in Sweden, may have no relevance whatsoever to application within the healthcare systems of other countries.

Further compounding these concerns is the quality of the journal in which the study was published. Impact factor measures the frequency with which an average article in a journal is cited over a set period of time. A score of 10 or higher is considered excellent. The ‘EMC Health Services Research’ journal’s impact factor stands at a modest 2.9. While respectable, this isn’t remarkably high, suggesting that the study’s findings might not carry the weight that those published in more prestigious journals might.

In conclusion, while the study brought forward valuable insights from a regional Swedish perspective, it’s essential to consider its limitations when forming a comprehensive understanding. The integration of AI into healthcare is a complex endeavour, with challenges both intrinsic to the healthcare system and in the broader societal context. Addressing these challenges requires collaborative efforts among healthcare entities, policymakers, and industry stakeholders. The investment in time, resources, and well-guided strategies, complemented by clear laws and policies, is paramount for the seamless and effective integration of AI in healthcare.

Links

https://bmchealthservres.biomedcentral.com/articles/10.1186/s12913-022-08215-8

Revolutionising Patient Data: The Role of Coding and AI in the NHS

First published 2023

The integration and effective management of patient data remain a considerable challenge in the National Health Service (NHS) practice. In hospital medicine and general practice, the information about patients lies in numerous databases that are often poorly unified and as a result, patient data is often hard or impossible to find. The vast oceans of data that the NHS has to manage require systematic organisation and easy retrieval mechanisms to ensure that medical professionals can access the information they need promptly and accurately.

Coding plays a pivotal role in addressing these challenges. A 2016 study found that doctors spent up to 52.9% of their time working on Electronic Patient Records (EPR), with much of this time spent ‘Coding’ (adding unique marker codes to patients’ records to clearly identify their conditions, treatments, and any other relevant information). The purpose of coding extends beyond mere organisation. It acts as a linguistic bridge, allowing various databases and systems within the NHS to communicate seamlessly. By assigning unique codes, a standard language is established, enabling different databases to become more integrated, which improves the accessibility and unification of patient information.

Contact

Furthermore, the significance of coding goes hand in hand with clinical utility. Coding is important to clearly surface and make clear significant diagnoses and treatments in the health records. By doing this, coding assists medical professionals by enhancing the visibility of crucial patient information. This optimises clinical workflows, as clinicians can easily find the data necessary to inform medical decisions, ultimately improving patient outcomes.

Moreover, coding facilitates better communication and alert systems across different healthcare settings. This helps highlight medical conditions to treating clinicians in different healthcare settings and can enable rapid alerting to clinicians, for example, if a patient is showing signs of sepsis (a life-threatening reaction to an infection). Such capabilities illustrate the crucial role that coding plays in real-time clinical decision-making, supporting clinicians in delivering timely and appropriate care.

Beyond manual data entry, advancements in technology present promising avenues to improve the coding process within the NHS. There are high complexity AI developments that can use natural language processing and machine learning techniques to read and interpret electronic text at a very large scale and then code the data. Such innovations come with the potential to dramatically streamline and refine the data coding process. At a trial at King’s College Hospital, it was found that a clinical coding AI called ‘Cogstack’ was able to triple the depth of coding within the space of a month. The implications of these technological breakthroughs for the NHS cannot be overstated. If these systems were implemented nationally, coding capacity will significantly increase, leading to more clinical hours for doctors to see patients. Additionally, it would also increase the overall efficiency and quality of care received by patients, by creating safer, higher quality data for care. These AI-driven tools, hence, are not just luxury add-ons but necessary instruments that can revolutionise the way patient data is managed and used within the NHS framework.

In conclusion, coding in NHS practice acts as a vital tool in improving data accessibility, integration, and clinical utility. Through coding, the NHS can overcome the challenges posed by disparate databases and improve the efficiency and effectiveness of patient care delivery. Thus, coding is not just a technical process but a clinical imperative that underpins the functionality and responsiveness of healthcare services within the NHS.

Links

https://digital.nhs.uk/developer/guides-and-documentation/building-healthcare-software/clinical-coding-classifications-and-terminology

https://www.nuance.com/asset/en_uk/campaigns/healthcare/pdfs/nuance-report-clinical-coder-en-uk.pdf

https://transform.england.nhs.uk/media/documents/NHSX_AI_report.pdf

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6510043/

https://pubmed.ncbi.nlm.nih.gov/31463251/

Balancing Individualised Care with Generalised Approaches in Medicine

First published 2022

The practice of medicine has perennially oscillated between two poles: the provision of individualised care and the adherence to generalised medical standards. Historically, physicians served specific communities, intimately familiar with each member, and were apt to deliver care rooted deeply in personal knowledge and context. An example of this can be seen in the traditional family doctor model, where the physician knew not just the medical history, but also the sociocultural background of each patient, leading to a highly personalised treatment approach. However, as medical science advanced and populations surged, a shift towards generalisation became inevitable. The rise of evidence-based medicine, backed by large-scale clinical studies, gave birth to standardised protocols that prioritised overarching principles and practices.

Contact

Yet, the age-old debate persists: should medicine cater to the collective or to the individual? While standardisation ensures consistent quality of care and is particularly beneficial for scalability and cost-effectiveness, it often overlooks the nuances of individual patient needs. For instance, the treatment guidelines for hypertension might suggest a particular class of medication for most individuals, but certain patients might respond differently due to genetic factors or co-existing health conditions. On the other hand, exclusively focusing on individual needs can strain already limited healthcare resources, given the time and attention each personalised treatment plan demands.

Henri de Mondeville, a renowned surgeon of the Middle Ages, is often credited for his forward-thinking approach to medicine, which emphasised the importance of individualised care. Living in the 14th century, a period marked by profound changes in the understanding of the human body and the nature of diseases, de Mondeville’s perspective was notably progressive. During this era, medicine was predominantly guided by ancient texts, with a strong inclination towards the teachings of Hippocrates and Galen. Treatments were often based on broad categorisations and humoral theories, which proposed that diseases were the result of imbalances in bodily fluids. Against this backdrop, de Mondeville’s assertion that “Anyone who believes that anything can be suited to everyone is a great fool, because medicine is practised not on mankind in general, but on every individual in particular,” was groundbreaking. By emphasising the need to treat every patient as a unique individual, he challenged the prevailing one-size-fits-all approach. This sentiment was not merely about distinguishing one patient from another based on symptoms, but a deeper call to understand the holistic context in which a patient existed. His views can be juxtaposed against prevalent practices like bloodletting, which, irrespective of individual nuances, was often prescribed as a universal remedy for various ailments. Through this lens, de Mondeville’s statement can be viewed not only as a clinical guideline but also as a philosophical stance on the ethics and approach of medical care.

As healthcare evolves, especially in the face of technological advancements and growing patient awareness, the weight of this debate grows heavier. Henri de Mondeville’s assertion that medicine is practised not on people in general but on every individual in particular brings to light a significant aspect of patient care, suggesting that the practice of medicine should be tailored to the unique circumstances of each individual. As posited by de Mondeville, medicine does not follow a one-size-fits-all approach but is rather a tailored art encompassing a patient and their context. This idea of considering a patient’s context is fundamentally important. Take the instance of chronic pain: where a generic solution might involve administering pain killers, understanding the patient’s individual context might reveal that the pain has psychological roots, perhaps stemming from depression or a tumultuous family situation. In such cases, a more appropriate intervention might involve lifestyle changes as opposed to medication.

Medicine is not merely about addressing physiological ailments but is intrinsically tied to making decisions that best align with the specific needs and circumstances of each patient. For instance, in dealing with an elderly individual suffering from both cancer and dementia, the optimal decision might lean towards palliative care aimed at alleviating pain rather than aggressive treatments. The emergence of precision medicine, which strives to tailor treatments at an individual level, reinforces de Mondeville’s perspective. This approach diverges from traditional medical practices, focusing instead on crafting personalised therapeutic plans based on a patient’s unique genetic, environmental, and lifestyle factors.

Contrarily, while de Mondeville’s statement highlights the importance of individualised care, it also beckons a counter perspective. Adopting a strictly individual approach can be burdensome, both in terms of time and resources. Given the constraints faced by healthcare systems like the NHS, providing bespoke care for every single patient might prove to be impractical. Furthermore, the realm of pharmacology often depends on a more generalised approach. Clinical trials, which form the bedrock of drug approvals, operate on generalised models to ascertain the efficacy and safety of potential treatments. Such generalisations are essential to validate correlations and to determine treatments that are universally effective. Moreover, an overemphasis on individual care might inadvertently introduce biases, compromising the principle of non-maleficence in medicine.

Furthermore, the advent of artificial intelligence in medicine underscores the importance of generalisation. AI systems are inherently designed to identify patterns across large data sets. These patterns, derived from generalised data, hold promise for shaping the future of medicine. While it’s undeniable that individual care is paramount, it’s equally imperative to recognize the utility and efficiency offered by generalised approaches.

In reflecting on de Mondeville’s statement, it becomes evident that while individualised care is essential, a balanced approach that marries both individual and generalised methods might be the most pragmatic way forwards in medicine. Emphasising one over the other might limit the potential for comprehensive and efficient patient care. It is in the amalgamation of both these approaches that the true essence and effectiveness of medical practice can be realised.

Links

https://www.azquotes.com/quote/1030374

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8731341/pdf/buffmedj145808-0018.pdf

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1114973/

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7786717/

https://www.england.nhs.uk/wp-content/uploads/2017/04/ppp-involving-people-health-care-guidance.pdf

Ethical and Practical Dimensions of Big Data in the NHS

First published 2022

Understanding the concept of Big Data in the field of medicine is relatively straightforward: it involves using extensive volumes of medical information to uncover trends or correlations that may not be discernible in smaller datasets. However, one might wonder why Big Data hasn’t been more widely applied in this context in the NHS. What sets industries like Google, Netflix, and Amazon apart, enabling them to effectively harness Big Data for providing precise and personalised real-time information based on online search and purchasing activities, compared to the National Health Service?

An examination of these thriving industries reveals a key distinction: they have access to data that is freely and openly provided by customers and is delivered directly and centrally to the respective companies. This wealth of detailed data encompasses individual preferences and aversions, facilitating accurate predictions for future online interactions.

Contact

Could it be feasible to use extensive volumes of medical data, derived from individual patient records, to uncover new risks or therapeutic possibilities that can then be applied on a personalised level to enhance patient outcomes? When we compare the healthcare industry to other sectors, the situation is notably distinct. In healthcare, medical records, which contain highly sensitive personal information, are carefully protected and not openly accessible. Typically, data remains isolated within clinic or hospital records, lacking a centralised system for sharing that would enable the rapidity and scale of data necessary to fully harness Big Data techniques. Medical data is also intricate and less readily “usable” in comparison to the data provided to major corporations, often requiring processing to render it into a readily usable format. Additionally, the technical infrastructure required for the movement, manipulation, and management of medical data is not readily accessible.

In a general sense, significant obstacles exist in terms of accessing data, and these obstacles encompass both philosophical and practical dimensions. To enhance the transformation of existing data into novel healthcare solutions, several aspects must be tackled. These encompass, among other things, the gathering and standardisation of diverse datasets, the careful curation of the resulting refined data, securing prior informed consent for the use of de-identified data, and the capacity to offer these datasets for further use by the healthcare and research communities.

To gain a deeper understanding of the opportunities within the clinical field and why the adoption and adaptation of these techniques haven’t been a straightforward transfer from other industries, it’s beneficial to examine both the similarities and distinctions between clinical Big Data and data used in other sectors. Industries typically work with what can truly be labeled as Big Data, characterised by substantial volume, rapid velocity, and diversity, but often exhibit low information density. These data are frequently freely obtained, stemming from an individual’s incidental digital activities in exchange for services, serving as a proxy indicator for specific behaviors that enable the anticipation of patterns, trends, and outcomes. Essentially, such data are acquired at the moment services are accessed, and they either exist or do not exist.

Comparable data can be found in clinical settings as well. For instance, during surgery, there is the continuous monitoring of physiological parameters through multiple devices, generating substantial volume, high velocity, and diverse data that necessitate real-time processing to identify data falling outside predefined thresholds, prompting immediate intervention by attending clinicians. On the other hand, there are instances of lower-volume data, such as the day-to-day accumulation of clinical test results, which contribute to updated diagnoses and medical management. Likewise, the analysis of population-based clinical data has the capability to forecast trends in public health, like predicting the timing of infectious disease outbreaks. In this context, velocity offers “real-time” prospective insights and allows for trend forecasting. The origin of the data is attributable to its source, whether it be a patient in the operating room or a specific geographical population experiencing the winter flu season.

The primary use of this real-time information is to forecast future trends through predictive modeling, without attempting to provide explanations for the findings. However, a more immediate focus of Big Data is the extensive clinical data already stored in hospitals, aiming to address the question of why specific events are occurring. These data have the potential, provided they can be effectively integrated and analysed, to offer insights into the causes of diseases, enable their detection and diagnosis, guide treatment and management, and facilitate the development of future drugs and interventions.

To assimilate this data, substantial computing power well beyond what an individual can manage is required, thus fitting the definition of Big Data. The data will largely be population-specific and then applied to individuals (e.g., examining patient groups with different disease types or processes to gain new insights for individual benefit). Importantly, this data will be collected retrospectively, rather than being acquired prospectively.

Lastly, while non-medical Big Data has often been incidental, freely available, and of low information density, clinical Big Data will be intentionally gathered, incurring costs (borne by someone), and characterised by high information density. This is more akin to business intelligence, where Big Data techniques are needed to derive measurements and detect trends (not just predict them) that would otherwise remain concealed or beyond human inspection alone.

Patient data, regardless of its nature, often seems to be associated with the medical institutions that hold it. However, it’s essential to recognise that these institutions function as custodians of the data; the data itself belongs to the patients. Access to and use of this data beyond clinical purposes necessitate the consent of the patients. This immediately poses a challenge when it comes to the rapid use of the extensive data already contained in clinical records.

While retrospective, hypothesis-driven research can be conducted on specific anonymised data, as is common in research, it’s important to note that once a study concludes, the data should ideally be deleted. This approach contradicts the principles of advancing medical knowledge, particularly when employing Big Data techniques that involve thousands to millions of data points requiring significant processing. Losing such valuable data at the conclusion of a project is counterproductive.

Prospective patient consent to store and use their data offers a more robust model, enabling the accumulation of substantial datasets that can be subsequently subjected to hypothesis-driven research questions. Although foregoing the use of existing retrospective data may appear wasteful, the speed (velocity) at which new data are generated in the NHS makes consented data far more valuable. Acquiring patient consent, however, often necessitates on-site personnel to engage with patients. Alternatively, options like patients granting blanket consent for data usage may be viable, provided that such consent is fully informed.

This dilemma has come to the forefront due to the implementation of the EU General Data Protection Regulation (GDPR) in 2018, triggering an international discourse on the sharing of Big Data in healthcare. In 2021, the UK government commissioned the ‘Goldacre Review’ into how to create big data sets, and how to ensure the “efficient and safe use of health data for research and analysis can benefit patients and the healthcare sector”. The review concluded that it is essential to invest in safe and trusted platforms for data and high-quality data curation to allow researchers and AI creators to realise the potential of the data. This data “represents deeply buried treasure, that can help prevent suffering and death, around the planet, on a biblical scale.”

Following the Goldacre Review, the UK government launched the ‘National Data Strategy’, which supports the creation of high-quality big data, and ‘Data Saves Lives’, which specifically sets out to “make better use of healthcare data and to save lives”. The ‘Data Saves Lives’ initiative exemplifies the progressive approach the UK has taken towards harnessing the power of Big Data in healthcare. Recognising the transformative potential of large-scale medical datasets, the initiative seeks to responsibly leverage patient data to drive innovations in medical research and clinical care. There’s a recognition that while industries like Netflix or Amazon can instantly access and analyse user data, healthcare systems globally, including the NHS, must manoeuvre through more complex ethical, legal, and logistical terrains. Patient data is not just another statistic; it is a deeply personal narrative that holds the key to both individual and public health solutions. Ensuring its privacy, obtaining informed consent, and simultaneously making it available for meaningful research is a balancing act, one that the NHS is learning to master.

In conclusion, the use of Big Data in the realm of healthcare differs significantly from its application in other industries, primarily due to the sensitive nature of the data and the ethical implications of its use. The potential benefits of harnessing this data are immense, from individualised treatments to large-scale public health interventions. Yet, the complexities surrounding its access and use necessitate a thoughtful, patient-centric approach. Initiatives like ‘Data Saves Lives’ signify the healthcare sector’s commitment to unlocking the potential of Big Data, while ensuring patients remain at the heart of the conversation. As the NHS and other global healthcare entities navigate this promising frontier, the underlying ethos must always prioritise patient welfare, trust, and transparency.

Links

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6502603/

https://www.gov.uk/government/publications/better-broader-safer-using-health-data-for-research-and-analysis

https://www.gov.uk/government/publications/uk-national-data-strategy/national-data-strategy

https://digital.nhs.uk/services/national-data-opt-out/understanding-the-national-data-opt-out/confidential-patient-information

Big Data: Two Sides of An Argument

First published 2022

In this contemporary era, technology is continually advancing, leading to the accumulation of personal data in the form of numerous digits and figures. The term ‘Big Data’ refers to data that contains greater variety, arriving in increasing volumes and with more velocity, which is often referred to as the three Vs. In simpler terms, big data encompasses extensive and intricate datasets, particularly those stemming from novel data sources. These datasets are of such immense volume that conventional data processing software is inadequate for handling them. Nevertheless, these vast pools of data can be harnessed to solve business challenges that were previously insurmountable. For example, ‘Big Data’ is required for AI to work properly. For the AI algorithms to correctly recognise and ‘Intelligently’ understand patterns and correlations, they need access to a huge amount of data. It is important that this big data has the correct ‘Volume, Velocity, and Variety’ (3 Vs).

Many individuals are concerned about safeguarding this intangible yet highly valuable aspect of their lives. Given the profound importance people place on their privacy, numerous inquiries emerge regarding the ultimate custodians of this information. What if it came to light that corporations were exploiting loopholes in data privacy regulations to further their own financial gains? Two articles examine the concept of exposing private information: “Private License Plate Scanners Amassing Vast Databases Open to Highest Bidders” (RT, 2014) and “Who Has The Right to Track You?” (David Sirota, 2014). While unveiling how specific businesses profit from the scanning of license plates and the collection of individuals’ personal data, both authors effectively employ a range of persuasive techniques to sway their readers.

Contact

Pathos serves as a rhetorical device that aims to evoke emotional responses from the audience. In the second article, titled “Who Has The Right to Track You?”, David Sirota adeptly employs pathos to establish a strong emotional connection with his readers. Starting with the article’s title and continuing with questions like, “Do corporations have a legal right to track your car?”, he deliberately strikes a chord of apprehension within the reader. Sirota uses phrases such as “mass surveillance” and “mass photography,” repeatedly emphasising the accumulation of “millions of license plate images” to instill a sense of insecurity in the reader.

Throughout the article, he maintains a tone of genuine concern and guardianship on his part, often addressing the reader in the second person and assuring them that he is an advocate for “individuals’ privacy rights.” This approach enables him to forge a connection with the audience, making them feel as though he is actively looking out for their well-being.

The author of the second article, RT, employs pathos to engage with readers from a contrasting standpoint. He employs phrases such as “inhibiting scanners would…create a safe haven…for criminals” and “reduce the safety of our officers, and it could ultimately result in lives lost”. These statements are crafted to instill fear in the audience, persuading them to consider the necessity of sacrificing their privacy for the sake of law enforcement’s ability to safeguard them. RT avoids using the term “mass surveillance” and instead employs more lighthearted expressions like “the scanners ‘scoop up 1,800 plates a minute'”. By using this less threatening language, such as “scoop up,” the author intends to alleviate any concerns readers may have about this practice, portraying it in a more benign light.

Both authors employ the rhetorical device of logos, which involves using logic and reason to persuade their respective audiences. Sirota, for instance, provides data such as the cameras in question “capturing data on over 50 million vehicles each month” and their widespread use in major metropolitan areas. This substantial data serves to evoke discomfort in the reader and cultivate a fundamental distrust in these surveillance systems. Sirota further invokes reason by highlighting that valuable information like “household income” is being collected to enable companies to target consumers more effectively. Through this logical approach, he underscores the ethical concerns regarding how companies disseminate such information to willing clients.

In contrast, RT employs logos to assuage the reader’s concerns about data collection. He emphasises that the primary users of this data collection are “major banks, tracking those defaulting on loans,” and the police, who use it to apprehend criminals. Essentially, RT is conveying to the reader that as long as they are not engaged in wrongdoing, there should be no cause for alarm. Moreover, he reassures the reader that illicit use of scanning procedures is an uncommon occurrence, citing an environment owner who states, “If we saw scanning like this being done, we would throw them out”. This logical argument is designed to ease the reader’s anxieties about the potential misuse of data collection systems.

Both authors employ ethos in their persuasive efforts, with Sirota demonstrating a stronger use of this rhetorical appeal. One factor contributing to the weakness of the first article is the credibility of its sources. In the RT article, the sources often appear to originate from heavily biased sources, such as the large corporations themselves. For instance, the person quoted as stating, “I fear that the proposed legislation would essentially create a safe haven in the Commonwealth for certain types of criminals, it would reduce the safety of our officers, and it could ultimately result in lives lost,” is not a law enforcement officer, attorney, or legislator; rather, it is Brian Shockley, the vice president of marketing at Vigilant, the corporate parent of Digital Recognition. It is problematic for the reader to be frightened into relinquishing their privacy by a corporation that stands to profit from it.

In contrast, Sirota cites sources with high credibility, or extrinsic ethos, throughout his article. He quotes ACLU attorney Catherine Crump, who states: “‘One could argue that the privacy implications of a private individual taking a picture of a public place are significantly different from a company collecting millions of license plate images…there may be a justification for regulation.” Sirota presents a relatable source representing the public’s interests from a legal perspective, rather than one aligned with a corporation seeking to gain from the situation.

The balance between corporate and national security interests on one hand, and individual privacy and rights on the other, continues to be a significant subject in our increasingly tech-driven society. The authors of the articles examined in this discussion skillfully employed ethos, pathos, and logos to build their cases regarding the use of private license plate scanners. Numerous journalists and news outlets have also contributed their perspectives on this matter, aiming to educate the public about both sides of the argument. While journalists and writers may present a particular viewpoint, it ultimately falls upon the reader to carefully contemplate all the ramifications of the debate.

Links

https://h2o.ai/wiki/big-data/

https://www.rt.com/usa/license-scanners-private-database-046/

https://inthesetimes.com/article/do-companies-have-a-right-to-track-you